Cardiomyopathy

I9_CARDMYO

cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42 Cause of death: ICD-10 — I42 2 out of 7 registries used, show all original rules.	7447
4. Check minimum number of events None	7447
5. Include endpoints I9_CARDMPRI I9_CARDMSEC I9_CARDMYOHYP I9_CARDMYOALC I9_CARDMYORESTR I9_CARDMYOOTH I9_CARDMYOINOTH	7853
6. Filter based on genotype QC (FinnGen only)	7853

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I30-I52
Name in latin: Cardiomyopathia

NAME	I9_CARDMYO
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_CARDMPRI\|I9_CARDMSEC\|I9_CARDMYOHYP\|I9_CARDMYOALC\|I9_CARDMYORESTR\|I9_CARDMYOOTH\|I9_CARDMYOINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I42
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I42
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiomyopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64595	19959	43679
Only index persons	45919	15193	30726
Unadjusted period prevalence (%)
Whole population	1.02	0.57	1.22
Only index persons	0.97	0.56	1.17
Median age at first event (years)
Whole population	61.32	64.86	59.69
Only index persons	61.74	64.65	60.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7853	2592	5261
Unadjusted period prevalence (%)	1.85	0.88	2.32
Median age at first event (years)	61.44	61.22	61.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7110: Matched controls
71092

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

323.0

350

I47.2

ICD-10 Finland

Ventricular tachycardia

842.1

323.0

822

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

1511

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

148.3

323.0

510

I50.9

ICD-10 Finland

Heart failure, unspecified

314.1

323.0

3510

220

I48

ICD-10 Finland

Atrial fibrillation and flutter

184.9

323.0

3288

329

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

11.7

323.0

1388

1442

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4503599627370496.0

323.0

4298

AN1

Coronary angiography

8.5

323.0

2095

3328

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

306.5

323.0

348

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1845.5

323.0

371

C09AA05

ATC

ramipril; oral

6.1

323.0

3559

10033

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

5368.7

323.0

2306

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

178.1

323.0

663

I42.8

ICD-10 Finland

Other cardiomyopathies

6490.3

323.0

606

K78

ICPC

Atrial fibrillation/flutter

30.2

323.0

962

366

XF404

NOMESCO Finland

Ambulatory ECG

21.0

323.0

1716

1062

C03CA01

ATC

furosemide; systemic

14.3

323.0

4638

8258

GD1LA

NOMESCO Finland

166.6

323.0

482

I48.1

ICD-10 Finland

Persistent atrial fibrillation

618.4

323.0

354

TFP34

NOMESCO Finland

Electrophysiological investigation

654.5

323.0

432

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

323.0

4092

18773

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

323.0

454

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

213.6

323.0

534

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

499.2

323.0

1637

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

12.6

323.0

3298

4562

C07AB07

ATC

bisoprolol; oral

11.8

323.0

5608

17062

XF400

NOMESCO Finland

ECG with 12 standard connections

4.2

323.0

1884

5603

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.4

323.0

1931

4564

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3554.6

323.0

349

201

Kela drug reimbursment

Chronic cardiac insufficiency

144.3

323.0

2882

334

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.7

323.0

2339

8241

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

194.2

323.0

539

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4455.4

323.0

430

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

351.3

323.0

338

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

3996.7

323.0

389

TFP20

NOMESCO Finland

Cardiodefibrillation

368.0

323.0

1291

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

12.0

323.0

3937

6677

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

70.8

323.0

538

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

177.2

323.0

571

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

783.1

323.0

1289

WX892

NOMESCO Finland

Monitored bed care

6.2

323.0

982

1799

I47.1

ICD-10 Finland

Supraventricular tachycardia

66.6

323.0

391

B01AF02

ATC

apixaban; oral

18.6

323.0

1008

627

C03DA01

ATC

spironolactone; oral

25.7

323.0

3095

2071

207

Kela drug reimbursment

Chronic arrhythmias

457.6

323.0

2359

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

10.5

323.0

907

973

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

822.2

323.0

1748

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

5517.1

323.0

523

C01AA05

ATC

digoxin; systemic

57.2

323.0

1764

407

I49.5

ICD-10 Finland

Sick sinus syndrome

413.7

323.0

431

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3576.6

323.0

351

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

3749.2

323.0

1006

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

17.9

323.0

3517

3681

B01AA03

ATC

warfarin; systemic

17.6

323.0

3182

3118

C01BD01

ATC

amiodarone; systemic

462.9

323.0

969

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

865.2

323.0

485

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

323.0

594

I50.0

ICD-10 Finland

Congestive heart failure

497.6

323.0

1908

C09DX04

ATC

valsartan and sacubitril; oral

6419.1

323.0

600

I50.1

ICD-10 Finland

Left ventricular failure

4243.2

323.0

1957

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7185.1

323.0

664

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

266.8

323.0

588

I49.3

ICD-10 Finland

Ventricular premature depolarization

22.1

323.0

707

353

I50

ICD-10 Finland

Heart failure

51.9

323.0

600

126

R06.0

ICD-10 Finland

Dyspnoea

3.8

323.0

2345

8072

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

507.5

323.0

2067

C07AA07

ATC

sotalol; systemic

15.4

317.0

541

379

M04AA01

ATC

allopurinol; systemic

3.9

314.9

1515

4634

K77

ICPC

Heart failure

43.6

310.0

388

I35.0

ICD-10 Finland

Aortic (valve) stenosis

33.2

306.8

408

130

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

304.3

290

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

7.0

299.3

790

1240

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

2782.8

289.2

278

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

2772.0

288.1

277

XF402

NOMESCO Finland

ECG with work load test

4.4

286.9

1173

3067

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

270.5

258

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

552.3

270.1

267

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

897.6

266.2

260

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

6.6

265.3

730

1206

Angiography of the heart and coronary arteries

5.5

263.1

853

1733

C01BC04

ATC

flecainide; systemic

125.2

257.3

277

XF640

NOMESCO Finland

15.3

257.1

438

303

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

9.0

256.2

572

687

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

233.6

223

1CX08

NOMESCO Finland

307.1

233.1

236

C07AB02

ATC

metoprolol; systemic

2.8

224.5

1747

7375

AP1

Catheterization of the left side of the heart

16.7

223.2

367

231

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

9.2

220.4

484

562

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

444.9

217.8

217

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.6

217.6

1942

8873

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

216.3

1754

7569

TPH07

NOMESCO Finland

Cathetrisation of artery

3.7

214.2

1064

3248

I34.1

ICD-10 Finland

Mitral (valve) prolapse

65.2

211.1

246

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.3

207.6

688

1417

TFJ02

NOMESCO Finland

Muscle biopsy of heart

+∞

206.2

197

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

91.0

205.5

229

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.9

201.0

1429

5644

TFP35

NOMESCO Finland

Electroanatomical mapping

504.0

198.5

197

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

18.2

198.0

315

181

I42

ICD-10 Finland

Cardiomyopathy

1859.3

197.6

191

I44.1

ICD-10 Finland

Atrioventricular block, second degree

227.3

193.4

199

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

19.8

191.3

295

155

WX872

NOMESCO Finland

Intensive care

6.0

190.3

562

1005

R4110

NOMESCO Finland

Physiotherapy

2.3

187.1

2142

11019

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

185.8

1987

9869

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

184.1

176

K84

ICPC

Heart disease other

10.3

183.6

377

386

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

13.5

180.9

324

250

A12BA01

ATC

potassium chloride; oral

5.9

180.0

535

963

M10.9

ICD-10 Finland

Gout, unspecified

4.2

178.4

746

1940

XFE00

NOMESCO Finland

Epicardial ultrasonography

11.2

177.9

348

324

C07AG02

ATC

carvedilol; oral

4.3

177.4

711

1776

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

4.3

175.0

712

1803

ZX120

NOMESCO Finland

Intravenous

3.4

168.7

920

2986

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

140.3

167.1

178

Z94.1

ICD-10 Finland

Heart transplant status

177.2

165.4

173

I25.2

ICD-10 Finland

Old myocardial infarction

4.1

163.2

688

1797

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

546.7

162.6

161

AS4

Physiological pacemaker insertion DDD (R)

800.8

160.1

157

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

156.9

1282

5428

C01DA14

ATC

isosorbide mononitrate; oral

2.7

156.3

1252

5239

AQ1

Conventional electrophysiological examination

779.8

156.0

153

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.3

155.1

878

2920

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.4

153.4

1538

7274

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

150.5

144

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

150.5

144

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

148.4

142

B01AB05

ATC

enoxaparin; parenteral

2.1

147.9

2194

12432

R02

ICPC

Shortness of breath/dyspnoea

3.1

145.6

920

3299

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

145.0

1916

10306

AS7

Arrhythmia pacemaker insertion VVI (R) S

1422.6

142.1

138

H02AB06

ATC

prednisolone; systemic

1.9

141.9

3226

21503

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

64.5

140.7

164

AP4

Myocardial biopsy

696.4

139.3

137

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

134.8

129

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

134.6

675

2034

Electrophysiological Special Examination

234.4

134.4

138

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

129.5

124

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

128.5

123

XF409

NOMESCO Finland

Other special ECG

89.9

126.5

141

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

126.4

1840

10212

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

125.3

120

B01AE07

ATC

dabigatran etexilate; oral

7.7

124.7

303

410

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.4

124.0

341

551

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

122.5

723

2456

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.1

121.0

408

844

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

120.1

115

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.2

119.9

1524

7949

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

119.2

562

1605

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

119.1

114

250

Kela drug reimbursment

+∞

119.1

114

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.8

118.2

826

3138

C08DA01

ATC

verapamil; systemic

6.0

117.3

340

588

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.7

116.8

283

381

A46

ICD-10 Finland

Erysipelas

2.4

116.1

1102

4989

B01AF01

ATC

rivaroxaban; oral

2.9

115.3

801

3028

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

59.3

113.6

134

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

112.7

1016

4468

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

111.7

107

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

111.7

107

C09AA02

ATC

enalapril; systemic

2.1

111.4

1594

8709

Initial pacemaker installation

1084.6

109.7

107

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

108.7

1972

11800

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

+∞

107.5

103

R55

ICD-10 Finland

Syncope and collapse

2.7

107.2

834

3369

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

1053.6

106.6

104

AA1AD

NOMESCO Finland

CT of head and brain

2.0

106.3

1680

9528

TK800

NOMESCO Finland

Hemodialysis

7.4

105.2

261

364

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

1033.1

104.5

102

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

1033.1

104.5

102

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

37.9

104.5

134

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

+∞

103.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.8

102.2

306

550

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

101.3

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

338.4

100.3

101

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

+∞

100.2

127

Kela drug reimbursment

Transplant complication

8.3

99.0

227

280

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

98.3

461

1305

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

24.4

97.0

139

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.2

96.1

558

1862

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.4

95.6

498

1534

K99

ICPC

Cardiovascular disease other

6.7

95.4

254

392

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

93.8

1300

6947

C10AA05

ATC

atorvastatin; oral

1.7

93.1

2737

18980

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

92.9

I45.9

ICD-10 Finland

Conduction disorder, unspecified

76.2

92.4

105

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

90.8

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

90.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

90.7

1155

5945

R03AC02

ATC

salbutamol; inhalant

1.7

89.4

3147

22894

AP2

Catheterization of the right side of the heart

109.2

89.1

K83

ICPC

Heart valve disease NOS

51.7

88.8

107

C10AA01

ATC

simvastatin; oral

1.7

87.8

3161

23102

A10BK01

ATC

dapagliflozin; oral

3.5

87.0

430

1269

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

86.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

86.5

714

2965

C09AA04

ATC

perindopril; oral

3.2

86.5

482

1559

WX740

NOMESCO Finland

Nitrogen oxide therapy

76.5

86.3

FL1AC

NOMESCO Finland

Left cardioangiography

7.9

85.4

202

262

XF600

NOMESCO Finland

Bloodpressure measurement

3.1

85.4

501

1681

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

29.4

85.3

116

M10

ICD-10 Finland

Gout

3.5

84.8

425

1267

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

838.0

84.7

L04AA06

ATC

mycophenolic acid; systemic

7.1

84.6

216

314

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

83.5

N18.8

ICD-10 Finland

Other chronic renal failure

5.1

83.0

273

548

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.3

82.2

228

372

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.7

81.6

610

2391

K80

ICPC

Cardiac arrhythmia NOS

3.5

81.3

402

1186

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

81.0

1953

12616

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

79.8

790

3602

WX722

NOMESCO Finland

PEEP

3.4

79.8

421

1305

I51.4

ICD-10 Finland

Myocarditis, unspecified

274.0

79.7

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

79.6

595

2330

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.2

78.9

441

1428

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

78.8

832

3912

Catheter ablation of arrhythmia

776.5

78.5

AS2

Ventricular pacemaker insertion VVI (R)

391.6

78.0

R04.0

ICD-10 Finland

Epistaxis

2.8

77.5

533

1983

AP3

Catheterization of the right and left side of the heart

202.1

77.3

A02BC02

ATC

pantoprazole; systemic

1.6

77.3

4105

32769

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

+∞

77.2

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.9

76.8

336

894

N19

ICD-10 Finland

Unspecified kidney failure

4.2

76.0

307

760

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

7.5

75.3

184

251

R03BB04

ATC

tiotropium bromide; inhalant

2.3

74.7

776

3617

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.6

74.2

225

411

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

74.0

1088

5895

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.8

73.6

331

902

B01AF03

ATC

edoxaban; oral

28.1

72.8

100

J01FF01

ATC

clindamycin; systemic

1.8

72.7

1700

10813

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

249.1

72.5

I44.0

ICD-10 Finland

Atrioventricular block, first degree

18.5

72.3

113

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

11.3

72.3

139

125

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

715.2

72.2

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

72.2

740

3424

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

72.0

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

72.0

3AC01

NOMESCO Finland

10.6

70.3

140

135

C01BA03

ATC

disopyramide; systemic

44.0

70.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

68.9

644

2845

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

68.8

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

68.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

68.3

1754

11440

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

674.4

68.1

Initial installation of the atrial pacemaker

674.4

68.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

68.0

624

2729

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

35.6

68.0

M10.0

ICD-10 Finland

Idiopathic gout

3.7

67.8

310

856

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

67.8

Catheterization and pressure measurement of the right side of the heart

46.0

66.8

A10BA02

ATC

metformin; oral

1.7

66.3

1946

13164

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

66.1

3838

30745

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

65.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.6

65.3

199

366

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

34.4

65.1

I20.09

ICD-10 Finland

Unstable angina

2.9

64.8

422

1514

7AX01

NOMESCO Finland

324.9

64.5

3A064

NOMESCO Finland

40.9

64.5

A11CC03

ATC

alfacalcidol; systemic

5.1

64.4

213

430

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

63.6

384

1309

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

63.6

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

6.9

63.5

164

243

I20.00

ICD-10 Finland

Unstable angina

3.9

63.2

272

713

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.6

61.9

299

864

J01CA04

ATC

amoxicillin; systemic

1.6

61.8

4927

42122

S97

ICPC

Chronic ulcer skin

2.9

61.5

393

1391

Z50.0

ICD-10 Finland

Cardiac rehabilitation

7.7

60.6

145

192

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

60.5

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

+∞

60.5

TK810

NOMESCO Finland

Hemofiltration

14.0

60.4

105

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

60.0

1799

12178

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

592.8

59.8

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

59.4

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

59.4

E87.5

ICD-10 Finland

Hyperkalaemia

6.1

58.8

165

274

C01BA01

ATC

quinidine; oral

34.9

58.5

R53

ICD-10 Finland

Malaise and fatigue

1.8

57.9

1154

6911

J01DB01

ATC

cefalexin; oral

1.5

57.2

5152

44796

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

57.0

481

2007

WX002

NOMESCO Finland

Sedation and analgesia

1.7

57.0

1274

7903

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

56.7

375

1357

A10BH05

ATC

linagliptin; oral

2.8

56.4

377

1373

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

56.3

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

+∞

56.3

AQ2

Electrophysiological electroanatomical examination

+∞

56.3

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

6.1

56.2

158

263

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

56.0

265

753

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

55.9

350

1221

WX882

NOMESCO Finland

High dependency care

3.8

55.8

251

684

Catheterization and pressure measurement of the left side of the heart

5.2

55.1

176

342

WX902

NOMESCO Finland

External defibrillation of heart

191.4

55.0

G47.3

ICD-10 Finland

Sleep apnoea

1.7

54.6

1350

8621

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

541.9

54.6

T90

ICPC

Diabetes non-insulin dependent

1.6

54.3

1558

10371

Cardiac muscle biopsy

+∞

54.2

N02BE01

ATC

paracetamol; systemic, rectal

1.6

54.2

5483

48579

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

5.0

54.0

180

367

I51.7

ICD-10 Finland

Cardiomegaly

531.7

53.6

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

13.6

53.5

C08DB01

ATC

diltiazem; oral

2.8

53.4

372

1389

I49.1

ICD-10 Finland

Atrial premature depolarization

7.1

52.9

133

190

ZX108

NOMESCO Finland

Inhalation

8.8

52.1

114

131

C03AA03

ATC

hydrochlorothiazide; oral

2.1

51.8

640

3198

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.1

51.6

169

338

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

51.6

364

1369

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

51.4

1625

11075

342

Kela drug reimbursment

Dronedarone

+∞

51.1

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

501.2

50.5

A10AE04

ATC

insulin glargine; parenteral

2.1

50.3

632

3183

C09AA01

ATC

captopril; oral

4.5

49.9

185

422

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.6

49.8

234

661

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

49.7

433

1834

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.8

49.7

346

1292

J01MA12

ATC

levofloxacin; systemic

1.7

49.5

1203

7618

I43.8*M10.0

ICD-10 Finland

Gout in the heart

491.1

49.4

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.8

49.3

216

576

42508

ICD-8 Finland

Cardiomyopathy, Alia definita

+∞

49.0

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

35.3

48.8

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

48.7

274

889

205

Kela drug reimbursment

Chronic hypertension

1.5

48.3

1889

13525

C09CA03

ATC

valsartan; oral

2.1

48.2

605

3043

R04.2

ICD-10 Finland

Haemoptysis

3.2

48.1

268

864

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

48.0

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

+∞

48.0

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

47.8

659

3443

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

47.6

2690

20846

A10BK03

ATC

empagliflozin; oral

2.2

47.4

502

2342

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.5

47.4

H02AB07

ATC

prednisone; oral

1.8

47.2

882

5142

742

NOMESCO Finland

37.8

47.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

47.1

891

5215

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

46.9

N02AX02

ATC

tramadol; systemic, rectal

1.5

46.7

2642

20452

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

46.6

396

1655

WX730

NOMESCO Finland

Conventional respirator

5.4

46.3

144

272

XFP02

NOMESCO Finland

460.6

46.3

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.1

46.3

273

915

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.6

46.3

352

1384

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.2

45.6

506

2410

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.1

45.5

264

876

B01AC04

ATC

clopidogrel; oral

1.7

45.3

1041

6465

E05.89

ICD-10 Finland

Other thyrotoxicosis

27.2

45.0

L28

ICPC

Limited function/disability (L)

1.8

45.0

937

5650

WX930

NOMESCO Finland

Thepapeutic hypothermia

231.3

45.0

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.7

44.9

204

561

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

44.8

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

44.8

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

+∞

44.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

44.8

387

1630

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.7

44.8

207

578

R50.9

ICD-10 Finland

Fever, unspecified

1.8

44.5

835

4867

N05CF01

ATC

zopiclone; oral

1.5

44.4

1957

14340

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

44.3

1127

7210

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

72.0

44.0

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

43.8

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

43.5

265

908

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

43.4

2075

15453

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.2

43.3

169

406

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.0

43.2

122

205

I48.3

ICD-10 Finland

Typical atrial flutter

94.6

42.8

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

42.7

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

42.7

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

42.7

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

42.7

307

1166

R2110

NOMESCO Finland

Giving the first information

2.4

42.7

368

1550

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.9

42.5

143

296

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

42.1

671

3693

C09CA01

ATC

losartan; oral

1.6

42.1

1481

10280

Z71.8

ICD-10 Finland

Other specified counselling

1.6

42.1

1268

8473

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

41.7

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

41.7

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

41.6

4731

52717

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

12.9

41.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

41.1

413

1878

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

40.8

460

2205

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

+∞

40.6

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

40.6

C01BD07

ATC

dronedarone; oral

+∞

40.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

40.5

374

1629

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

27.7

40.2

I48.4

ICD-10 Finland

Atypical atrial flutter

399.6

40.1

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

39.9

247

856

I45.3

ICD-10 Finland

Trifascicular block

88.6

39.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

39.6

647

3590

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

39.6

ZXA05

NOMESCO Finland

Left side

1.5

39.5

1582

11297

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

39.2

468

2299

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

9.7

39.0

K29

ICPC

Cardiovascular sympt/complt other

2.7

38.9

277

1047

I45.6

ICD-10 Finland

Pre-excitation syndrome

137.4

38.7

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

105.6

38.7

H03BB01

ATC

carbimazole; oral

3.0

38.6

229

771

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.5

38.6

141

318

AB2

AVR bio, stent

+∞

38.6

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

38.4

481

2409

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

38.3

1737

12722

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

38.3

828

5031

T92

ICPC

Gout

3.7

38.0

174

483

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

72.2

37.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

37.9

1191

8019

E85.9

ICD-10 Finland

Amyloidosis, unspecified

20.9

37.8

C02EA02

ATC

2.4

37.6

338

1453

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

37.5

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

37.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

37.4

1976

14924

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

37.3

393

1826

E66.8

ICD-10 Finland

Other obesity

2.7

37.3

267

1013

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.5

37.2

112

205

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.5

37.1

309

1278

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

369.1

37.0

AR5

Catheter ablation of arrhythmia, target: atrial flutter

369.1

37.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

37.0

212

698

J01MA14

ATC

moxifloxacin; systemic

1.9

36.9

548

2933

FM1CD

NOMESCO Finland

Very extensive CT of heart

36.4

36.8

FXE00

NOMESCO Finland

Use of ECLA

190.9

36.8

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

100.5

36.7

C07AB03

ATC

atenolol; systemic

2.2

36.6

385

1788

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

36.5

AS5

Biventricular heart failure pacemaker insertion VVI (R)

+∞

36.5

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

36.2

791

4819

A12AA04

ATC

calcium carbonate; oral

4.8

36.1

123

259

S18

ICPC

Laceration/cut

1.4

36.0

2557

20370

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

80.5

35.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

35.5

1778

13256

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

35.4

AC4

MVP

+∞

35.4

AB1

AVR mechanical

+∞

35.4

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

5.6

35.2

105

190

I45.2

ICD-10 Finland

Bifascicular block

43.2

34.9

A10BH01

ATC

sitagliptin; oral

1.8

34.8

625

3577

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

34.6

528

2854

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

7.4

34.4

113

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

34.4

AA1

Conventional CABG

3.7

34.1

155

428

SPAT1263

SPAT

Sampling

1.4

33.8

2346

18552

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

175.7

33.7

J81

ICD-10 Finland

Pulmonary oedema

13.9

33.7

XF406

NOMESCO Finland

High resolution ECG

93.0

33.7

N18.0

ICD-10 Finland

End-stage renal disease

5.8

33.5

166

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

33.3

269

1094

A10BB12

ATC

glimepiride; oral

1.9

33.3

488

2598

B01AB04

ATC

dalteparin; parenteral

2.3

33.3

316

1398

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

32.9

164

488

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

32.9

282

1186

I44.6

ICD-10 Finland

Other and unspecified fascicular block

90.5

32.7

N17.8

ICD-10 Finland

Other acute renal failure

5.6

32.5

172

RS221

NOMESCO Finland

4.3

32.5

124

293

UJF32

NOMESCO Finland

Coloscopy

1.5

32.5

1496

10933

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

32.4

2193

17235

WW200

NOMESCO Finland

Immunization

3.0

32.3

194

660

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

32.3

I42.4

ICD-10 Finland

Endocardial fibroelastosis

+∞

32.3

I43.1

ICD-10 Finland

Cardiomyopathy in metabolic diseases

+∞

32.3

R4120

NOMESCO Finland

Occupational therapy

2.1

32.2

386

1897

SPAT1097

SPAT

Recording of ECG

1.6

32.0

817

5191

A28

ICPC

Limited function/disability NOS

1.6

32.0

872

5639

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

32.0

1450

10558

R07.3

ICD-10 Finland

Other chest pain

1.9

32.0

507

2779

I51.9

ICD-10 Finland

Heart disease, unspecified

318.3

31.9

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

31.8

847

5443

K28

ICPC

Limited function/disability (K)

3.4

31.5

157

468

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

5.8

31.4

156

C01BB02

ATC

mexiletine; systemic

24.6

31.3

AK1

HTX (heart transplant)

+∞

31.3

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

31.0

226

868

J96.0

ICD-10 Finland

Acute respiratory failure

5.2

30.9

191

K04

ICPC

Palpitations/awareness of heart

2.8

30.6

207

759

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.4

30.6

153

457

E66.9

ICD-10 Finland

Obesity, unspecified

3.0

30.4

177

591

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

30.3

386

1947

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.4

30.3

111

253

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

30.2

212

Kela drug reimbursment

Gout

3.2

30.2

165

527

WX110

NOMESCO Finland

Local anesthesy

1.3

30.1

3944

34315

XF622

NOMESCO Finland

Measurement of minute volume of heart

16.7

30.1

I95.9

ICD-10 Finland

Hypotension, unspecified

4.5

30.1

110

250

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.5

30.0

108

242

K60

ICPC

Cardiovascular, Result test/procedure

7.4

29.5

J96.1

ICD-10 Finland

Chronic respiratory failure

3.6

29.3

136

383

SPAT1254

SPAT

Administration of medicine

1.6

29.3

786

5054

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

29.3

284

1270

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

29.3

2195

17481

AT7

Replacing the pacemaker VVI (R) S

+∞

29.2

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

29.2

FXG00

NOMESCO Finland

Insertion and use of IABP

24.2

29.1

5AB14

NOMESCO Finland

18.1

29.1

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

29.0

139

402

J01DA01

ATC

[U] cefalexin; systemic

1.3

29.0

3691

31892

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

28.9

227

910

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

293.0

28.8

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

80.4

28.7

XX3BW

NOMESCO Finland

103.8

28.6

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.8

28.6

195

719

J01FA06

ATC

roxithromycin; oral

1.4

28.3

2192

17528

Q23.11

ICD-10 Finland

Bicuspid aortic valve

17.7

28.3

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

17.7

28.3

R42

ICD-10 Finland

Dizziness and giddiness

1.5

28.1

1153

8193

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

28.1

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

28.1

G04BE03

ATC

sildenafil; oral

3.2

28.1

152

483

SPAT1255

SPAT

Intravenous administration of medicine

2.0

28.0

385

1999

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

27.9

246

1050

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.4

27.6

139

418

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

27.5

257

1127

ZXA00

NOMESCO Finland

Right side

1.4

27.4

1616

12319

B03XA02

ATC

darbepoetin alfa; parenteral

3.6

27.4

126

353

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.4

27.3

155

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

27.1

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

27.1

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.1

26.9

170

C02EA01

ATC

4.1

26.9

108

269

L04AX01

ATC

azathioprine; systemic

2.3

26.9

254

1122

R03BA02

ATC

budesonide; inhalant

1.5

26.8

890

6026

WX890

NOMESCO Finland

Intesive care monitoring

6.2

26.8

119

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

26.8

351

1790

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

26.8

266

1203

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

26.7

284

1325

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

26.7

264

1192

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

26.7

962

6639

R60.0

ICD-10 Finland

Localized oedema

1.7

26.7

582

3533

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

27.8

26.6

B01AB10

ATC

tinzaparin; parenteral

1.9

26.6

392

2091

J01AA02

ATC

doxycycline; systemic

1.3

26.5

4747

42820

J94.8

ICD-10 Finland

Other specified pleural conditions

3.6

26.4

120

333

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

26.4

379

2002

L04AD01

ATC

ciclosporin; systemic

3.3

26.3

134

408

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

26.1

130

389

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

26.0

I40.0

ICD-10 Finland

Infective myocarditis

+∞

26.0

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

26.0

4255A

ICD-9 Finland

Cardiomyopathy, Alcoholic cardiomyopathy

+∞

26.0

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

26.0

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

26.0

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

26.0

3A149

NOMESCO Finland

60.2

25.9

K79

ICPC

Paroxysmal tachycardia

16.5

25.7

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

261.4

25.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

25.7

1224

8952

I49.2

ICD-10 Finland

Junctional premature depolarization

93.7

25.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.6

25.6

100

R18

ICD-10 Finland

Ascites

3.1

25.5

141

456

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

25.4

560

3404

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

25.4

926

6402

WX402

NOMESCO Finland

General anaesthesia

1.5

25.4

843

5709

FN1AD

NOMESCO Finland

CT of coronary arteries

4.3

25.2

228

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

+∞

25.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

25.0

283

1357

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

24.9

432

2437

SPAT1325

SPAT

Vaccination

1.3

24.9

2022

16218

M01AH05

ATC

etoricoxib; oral

0.8

24.8

2482

29306

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

24.8

327

1672

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

24.8

180

690

C09CA06

ATC

candesartan; oral

1.5

24.8

1128

8171

120

NOMESCO Finland

70.1

24.8

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.8

24.8

124

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

250.9

24.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

24.6

2719

22809

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

130.4

24.6

R11

ICD-10 Finland

Nausea and vomiting

1.9

24.4

392

2153

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

24.4

263

1237

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

24.4

330

1705

ZX197

NOMESCO Finland

24.4

24.3

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

24.3

257

1199

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

34.6

24.2

K92.1

ICD-10 Finland

Melaena

2.0

24.2

305

1531

SPAT1260

SPAT

Consultation of another employee

1.5

24.2

942

6601

K05

ICPC

Irregular heartbeat other

3.2

24.2

129

407

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

24.0

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

24.0

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

23.9

337

1767

C08CA02

ATC

felodipine; oral

1.7

23.8

553

3412

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

23.8

640

4112

E86

ICD-10 Finland

Volume depletion

2.9

23.8

150

530

A08

ICPC

Swelling

2.3

23.7

222

977

SPAT1104

SPAT

Monitoring of emergency patient

1.9

23.7

353

1887

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

125.4

23.6

F1279

NOMESCO Finland

125.4

23.6

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

125.4

23.6

SPAT1285

SPAT

Provision of consultation response

2.0

23.5

306

1557

R4190

NOMESCO Finland

Nutritional therapy

2.4

23.5

209

898

SPAT1262

SPAT

Handing over of treatment supplies

1.4

23.4

1076

7800

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

23.3

409

2316

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.1

23.3

227

C01BC03

ATC

propafenone; systemic

46.8

23.3

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

23.3

403

2273

XG466

NOMESCO Finland

Sleep oxymetry

2.4

23.2

201

851

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

23.2

1639

12826

AT4

Physiological pacemaker replacement DDD (R)

+∞

22.9

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

22.9

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

22.9

A10AE05

ATC

insulin detemir; parenteral

2.0

22.9

310

1600

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

11.7

22.9

K22

ICPC

Risk factor cardiovascular disease

2.0

22.9

295

1496

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

22.7

462

2740

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

30.1

22.7

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

22.7

283

1415

5CM18

NOMESCO Finland

10.1

22.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

22.6

227

1031

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.3

22.6

196

I11

ICD-10 Finland

Hypertensive heart disease

8.0

22.6

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.4

22.6

187

2BD01

NOMESCO Finland

20.7

22.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

22.5

1746

13858

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

7.1

22.5

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

22.4

249

1187

I45.0

ICD-10 Finland

Right fascicular block

11.8

22.4

R00.2

ICD-10 Finland

Palpitations

2.1

22.4

248

1179

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.4

22.4

124

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

13.1

22.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

22.3

135

464

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

45.1

22.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

22.1

667

4406

FA1AC

NOMESCO Finland

Upper cavography

52.1

22.1

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

21.9

941

6719

XF602

NOMESCO Finland

Bloodpressure monitoring

4.7

21.9

161

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

21.9

665

4399

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.9

21.9

352

1937

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

+∞

21.9

FN2EG

NOMESCO Finland

Catheter-based alcohol septal ablation

+∞

21.9

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

21.7

156

598

I45.8

ICD-10 Finland

Other specified conduction disorders

38.7

21.7

A02BC01

ATC

omeprazole; systemic

1.4

21.7

1533

11981

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

21.6

376

2124

M79.6

ICD-10 Finland

Pain in limb

1.3

21.6

1811

14527

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

220.5

21.6

C10AA03

ATC

pravastatin; oral

1.8

21.5

416

2433

C02DE01

ATC

5.4

21.5

122

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.9

21.5

235

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

21.4

268

1341

TFN04

NOMESCO Finland

7.1

21.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

21.2

586

3786

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

21.1

607

3962

WX900

NOMESCO Finland

Resuscitation

7.9

21.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

21.1

543

3445

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.5

21.1

168

K07

ICPC

Swollen ankles/oedema

2.2

21.0

214

982

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

21.0

180

758

J20

ICD-10 Finland

Acute bronchitis

1.7

21.0

471

2878

FM2CE

NOMESCO Finland

11.9

20.9

AR8

Catheter ablation of arrhythmia, target: left ventricular tachycardia

+∞

20.8

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

+∞

20.8

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.9

20.8

217

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

20.7

589

3833

A04

ICPC

Weakness/tiredness general

1.6

20.6

586

3816

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

20.5

165

673

288

Kela drug reimbursment

Febuxostat

9.0

20.5

L04AA01

ATC

[U] ciclosporin; systemic

3.3

20.5

105

323

Coronary artery bypass surgery

2.7

20.4

139

517

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.7

20.3

237

SPAT1252

SPAT

Overall medication plan or its review

1.8

20.3

386

2247

XF620

NOMESCO Finland

Examination of circulation with color method

8.8

20.3

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.9

20.1

292

1549

132

Kela drug reimbursment

Sarcoidosis

5.0

20.1

132

R06

ICPC

Nose bleed/epistaxis

3.0

20.1

115

381

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.9

20.0

123

430

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

35.8

19.8

FPE10

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial electrode

+∞

19.8

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

19.8

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

+∞

19.8

4278A

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[SICK SINUS-SYNDROMA]

+∞

19.8

FLE10

NOMESCO Finland

Myotomy or myectomy of left ventricle for outlet obstruction

+∞

19.8

AD1

TVP

+∞

19.8

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

19.7

189

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.2

19.6

211

990

V03AE01

ATC

polystyrene sulfonate; oral

3.7

19.5

230

M04AA03

ATC

febuxostat; oral

9.8

19.5

H02AB04

ATC

methylprednisolone; systemic

1.5

19.5

728

5047

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

19.4

935

6816

J46

ICD-10 Finland

Status asthmaticus

2.8

19.4

127

460

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

8.4

19.3

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.9

19.2

118

412

A10BJ02

ATC

liraglutide; parenteral

2.6

19.1

136

520

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

4.0

19.1

195

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.8

19.1

121

430

M10.3

ICD-10 Finland

Gout due to impairment of renal function

8.6

19.1

C10AX09

ATC

ezetimibe; oral

1.5

18.9

593

3948

I95.2

ICD-10 Finland

Hypotension due to drugs

5.4

18.9

107

NHQ40

NOMESCO Finland

Amputation of toe

3.2

18.9

101

321

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

18.8

234

1172

R03AC03

ATC

terbutaline; inhalant

1.5

18.8

656

4478

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

18.7

4278X

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[DYSRHYTMIAE CORDIS ALIA DEFINITA]

+∞

18.7

5401

FHL

Pacemaker installation, transvenous electrode

+∞

18.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

18.7

646

4399

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.6

18.7

244

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

13.4

18.7

N05BA01

ATC

diazepam; systemic, rectal

1.5

18.6

699

4848

Aortic Valve Replacement (AVR)

190.4

18.5

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

190.4

18.5

C01EB17

ATC

ivabradine; oral

190.4

18.5

N05BA04

ATC

oxazepam; oral

1.4

18.5

1224

9429

R05

ICD-10 Finland

Cough

1.4

18.5

975

7226

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

18.5

169

737

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

3.6

18.4

237

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.7

18.3

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

44.1

18.2

FM1AD

NOMESCO Finland

CT of heart

44.1

18.2

I27.0

ICD-10 Finland

Primary pulmonary hypertension

25.1

18.2

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.6

18.2

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

18.1

158

672

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

18.1

153

643

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.6

18.1

133

519

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

9.8

18.1

SPAT1251

SPAT

Organisation of medication

2.2

18.0

187

867

RS222

NOMESCO Finland

3.5

18.0

247

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

18.0

426

2642

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

17.8

945

7008

Z82.7

ICD-10 Finland

Family history of congenital malformations, deformations and chromosomal abnormalities

11.9

17.7

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.0

17.7

240

1241

5244

FHL

Heart transplantation

+∞

17.7

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

17.7

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

17.7

T82.1

ICD-10 Finland

Mechanical complication of cardiac electronic device

+∞

17.7

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

+∞

17.7

AC2

MVR bio

+∞

17.7

Mitral valve plasty

+∞

17.7

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

17.7

283

Kela drug reimbursment

Ivabradine

+∞

17.7

L17

ICPC

Foot/toe symptom/complaint

1.3

17.6

1265

9870

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

17.6

308

1747

N06AX11

ATC

mirtazapine; oral

1.3

17.6

1569

12637

R03DA04

ATC

theophylline; systemic, rectal

1.8

17.4

295

1655

K90

ICPC

Stroke/cerebrovascular accident

2.3

17.4

165

734

FM1BD

NOMESCO Finland

Extensive CT of heart

10.7

17.4

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

17.3

222

1124

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

17.3

309

1762

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.5

17.3

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.8

17.3

110

392

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.9

17.2

184

RS220

NOMESCO Finland

3.4

17.0

242

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.7

17.0

201

A41.8

ICD-10 Finland

Other specified sepsis

3.0

16.9

330

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

19.3

16.8

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.9

16.8

255

1379

A10BB01

ATC

glibenclamide; oral

1.9

16.7

248

1328

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

16.7

359

2168

I97.0

ICD-10 Finland

Postcardiotomy syndrome

11.1

16.7

WVA20

NOMESCO Finland

Medicine administration

2.6

16.7

125

494

FKC61

NOMESCO Finland

Repair of mitral valve insufficiency by a transluminally inserted clip

+∞

16.7

ASX

Other pacemaker insertion

+∞

16.7

4029B

ICD-9 Finland

Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]

+∞

16.7

TFP33

NOMESCO Finland

Simple electrophysiological investigation (e.g. ventricular stimulation)

+∞

16.7

3A560

NOMESCO Finland

35.1

16.6

FM1DE

SPAT

15.0

16.6

349

Kela drug reimbursment

Febuxostat

8.8

16.6

Z31.5

ICD-10 Finland

Genetic counselling

2.1

16.5

189

915

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

16.5

774

5609

I51.8

ICD-10 Finland

Other ill-defined heart diseases

170.3

16.5

WW500

NOMESCO Finland

Blood transfusion

2.0

16.4

222

1150

E85.89

ICD-10 Finland

Other amyloidosis

20.1

16.4

ZZA00

NOMESCO Finland

Split skin graft

2.2

16.3

168

775

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.0

16.3

315

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

16.3

869

6444

TK830

NOMESCO Finland

Ultrafiltration

40.1

16.3

5253

FHL

Cardiac lung machine

4.6

16.2

123

RD210

NOMESCO Finland

2.8

16.2

102

364

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

3.6

16.2

205

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

6.2

16.1

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

16.1

377

2331

J01CF05

ATC

flucloxacillin; systemic

2.1

16.1

191

939

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

16.1

114

436

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

16.0

138

585

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

18.5

16.0

R05

ICPC

Cough

1.4

15.9

1064

8192

R57.0

ICD-10 Finland

Cardiogenic shock

21.0

15.9

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

2.0

15.9

192

952

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

15.9

215

1113

137

Kela drug reimbursment

Uraemia requiring dialysis

4.3

15.9

135

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

6.2

15.8

J01MA02

ATC

ciprofloxacin; systemic

1.3

15.8

2244

19128

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

15.8

141

612

WX213

NOMESCO Finland

Lower leg blockade

4.9

15.7

105

N30.0

ICD-10 Finland

Acute cystitis

1.5

15.7

561

3843

R03BA05

ATC

fluticasone; inhalant

1.4

15.7

836

6199

E66.0

ICD-10 Finland

Obesity due to excess calories

4.0

15.6

156

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

15.6

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

15.6

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

15.6

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

15.6

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

+∞

15.6

Q21.10

ICD-10 Finland

Persistent ostium secundum

9.2

15.6

160

Kela drug reimbursment

exenatide

2.6

15.6

114

445

E06.4

ICD-10 Finland

Drug-induced thyroiditis

85.2

15.6

Q21.19

ICD-10 Finland

Atrial septal defect NOS

13.7

15.5

V03AE02

ATC

sevelamer; oral

6.8

15.4

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.3

15.4

1081

SPAT1281

SPAT

Other administrative function

1.6

15.3

396

2515

C08CA01

ATC

amlodipine; oral

1.3

15.3

2027

17131

A06AD11

ATC

lactulose; oral

1.4

15.2

808

5988

J45

ICD-10 Finland

Asthma

1.6

15.2

421

2724

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

15.1

298

I24.0

ICD-10 Finland

Coronary thrombosis not resulting in myocardial infarction

11.8

15.0

H02AB09

ATC

hydrocortisone; systemic

2.4

15.0

123

511

M10.2

ICD-10 Finland

Drug-induced gout

9.4

14.9

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

14.9

116

469

40299

ICD-8 Finland

Hypertensive heart disease

6.5

14.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

14.8

524

3588

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.7

14.7

170

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

14.7

419

2727

I44.4

ICD-10 Finland

Left anterior fascicular block

18.4

14.7

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.7

14.6

FFW96

NOMESCO Finland

Other operation on atria

+∞

14.6

T86.2

ICD-10 Finland

Heart transplant failure and rejection

+∞

14.6

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

+∞

14.6

I40.8

ICD-10 Finland

Other acute myocarditis

+∞

14.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

14.6

183

3156

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

14.6

3871

35195

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.1

14.5

138

PD5AD

NOMESCO Finland

CT of aorta

3.1

14.5

252

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.0

14.5

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

150.2

14.5

RS230

NOMESCO Finland

5.8

14.4

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

6.7

14.4

A07AA02

ATC

nystatin; oral

1.7

14.3

313

1901

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.9

14.3

294

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.0

14.2

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.1

14.2

250

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

14.2

316

1928

JN4AD

NOMESCO Finland

Body CT examination

1.6

14.2

416

2726

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.7

14.2

357

SPAT1301

SPAT

No procedures

1.3

14.2

1676

13947

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.3

14.1

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

14.1

159

766

R03BA01

ATC

beclometasone; inhalant

1.4

14.1

665

4823

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

4.3

14.0

119

R03AC13

ATC

formoterol; inhalant

1.8

14.0

231

1285

C08CA05

ATC

nifedipine; systemic

1.6

13.9

335

2087

R31

ICD-10 Finland

Unspecified haematuria

1.4

13.9

578

4090

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

15.8

13.9

I46.1

ICD-10 Finland

Sudden cardiac death, so described

53.4

13.8

EBA00

NOMESCO Finland

Extraction of tooth

1.3

13.8

1721

14407

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

13.8

384

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

13.7

545

3819

SPAT1310

SPAT

Counselling related to known health issue

1.3

13.7

1640

13651

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

3.9

13.7

141

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

13.7

336

2108

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

13.6

683

5003

J45.8

ICD-10 Finland

Mixed asthma

2.2

13.6

144

676

3AE00

NOMESCO Finland

75.2

13.6

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.2

13.5

133

603

AM4

VAD (use of the left and / or right side mechanical support (other than IABP)

+∞

13.5

AT8

Physiological pacemaker replacement DDD (R) S

+∞

13.5

42297

ICD-8 Finland

Acute myocarditis, Suspecta

+∞

13.5

ATA

Biventricular pacemaker replacement VVI (R) S

+∞

13.5

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

+∞

13.5

FJA00

NOMESCO Finland

Biopsy of right ventricle

+∞

13.5

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003396) Base excess in Arterial blood by calculation

1631

6105

3.11

322.35

12.0

6.4

0.7

0.9

mmol/l

1.28

1310

4700

(3014111) Lactate [Moles/volume] in Serum or Plasma

1359

4660

3.32

310.48

12.6

6.2

1.5

1.3

mmol/l

3.07

1298

4475

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2967

13682

2.88

307.65

2.8

2.0

3.0

2.8

mg/l

3.84

2623

11404

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1642

6128

3.12

307.65

12.0

6.4

5.0

5.1

kpa

2.41

1559

5847

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2401

8619

3.57

307.65

6.7

3.4

0.8

mmol/l

0.89

2275

7997

(3022948) Iron [Moles/volume] in Serum or Plasma

2922

8092

5.16

307.65

3.4

2.2

13.3

13.6

umol/l

1.22

2783

7422

(3032080) INR in Blood by Coagulation assay

4505

22534

3.34

307.65

21.0

4.4

1.6

1.1

inr

109.33

1253

6055

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

839

1326

6.96

307.65

5.8

2.5

0.4

u/ml

0.02

520

696

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2769

10090

3.69

307.65

6.8

2.9

545.7

510.9

ng/l

0.13

2594

7892

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

745

1235

6.56

307.65

2.5

1.7

11.1

mg/l

0.02

690

1149

(3000991) Gas panel - Venous blood

1412

4457

3.64

307.65

14.3

7.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1639

6126

3.12

307.65

12.0

6.4

11.3

12.7

kpa

28.50

1553

5839

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4026

21490

2.79

307.65

4.0

2.5

174.1

163.1

ug/l

0.77

3812

19555

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1387

4085

3.91

307.65

3.1

1.9

17.2

6.5

ug/l

10.82

1270

3451

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3931

21099

2.73

307.65

6.3

2.8

89.4

83.2

ng/l

0.06

3228

14951

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1875

7204

3.11

307.65

8.8

5.3

1.1

1.0

mmol/l

32.73

1762

6694

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

877

2113

4.55

307.65

2.5

1.7

33.4

39.5

u/l

10.28

637

1896

(3020779) Urea [Moles/volume] in Serum or Plasma

1700

4706

4.33

307.65

14.8

6.1

12.1

9.3

mmol/l

35.25

1625

4463

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5467

13471

11.07

307.65

7.5

1.8

2540.2

675.1

ng/l

102.67

5189

10940

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2323

3581

8.79

307.65

5.5

1.9

406.0

84.4

ng/l

95.63

2250

3150

(3027456) Digoxin [Moles/volume] in Serum or Plasma

696

78.63

307.65

3.0

1.6

0.8

nmol/l

0.16

532

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2768

6891

5.66

307.65

3.5

2.3

22.6

24.3

7.39

2487

5792

(3022217) INR in Platelet poor plasma by Coagulation assay

2097

5473

4.86

307.65

43.6

9.9

1.8

1.1

inr

31.28

208

990

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2818

7433

5.35

307.65

3.4

2.2

2.3

g/l

3.98

2674

6813

(3023368) Bacteria identified in Blood by Culture

3048

16040

2.47

305.85

5.9

3.9

—

(3012544) pH of Venous blood

1434

5173

3.17

300.31

6.2

3.5

7.4

—

(3002032) Base excess in Venous blood by calculation

1402

5002

3.19

299.08

6.1

3.5

1.8

1.7

mmol/l

0.23

1170

4004

(3016502) Oxygen saturation in Arterial blood

1480

5459

3.11

298.16

12.9

6.8

94.9

96.0

6.33

1437

5254

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1925

8208

2.78

297.31

5.0

1.9

32.0

29.1

52.70

1883

7994

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1400

5014

3.18

296.55

6.2

3.5

5.9

5.8

kpa

4.30

1359

4890

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

892

2452

3.98

283.73

6.7

4.0

23.9

24.0

mmol/l

0.15

832

2220

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

857

2399

3.89

265.04

4.0

3.2

4.2

4.5

pmol/l

12.44

792

2110

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4206

26802

2.23

255.69

11.1

5.3

1.2

mmol/l

62.80

3964

23965

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1327

5057

2.95

248.99

13.9

7.1

123.3

123.2

g/l

0.06

1305

4854

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1924

8883

2.54

247.66

2.1

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4481

29685

2.19

241.89

11.7

6.0

1.2

mmol/l

68.69

3864

24933

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4571

30531

2.19

241.45

9.0

6.4

14.4

11.7

umol/l

27.41

4406

28900

(3014576) Chloride [Moles/volume] in Serum or Plasma

1630

7062

2.65

238.33

12.5

6.4

104.1

104.5

mmol/l

2.70

1603

6924

(3018418) pH of Serum or Plasma

3018

17213

2.22

237.01

5.8

3.8

7.4

0.74

571

3151

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1534

6468

2.70

236.68

7.4

4.4

261.5

243.7

u/l

3.21

1457

6094

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1465

6037

2.75

236.41

2.0

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

903

2838

3.46

233.78

15.7

8.3

24.1

24.2

mmol/l

0.55

844

2664

(3013826) Glucose [Moles/volume] in Serum or Plasma

4990

34966

2.17

226.87

9.1

4.1

7.0

6.8

mmol/l

4.45

4797

32625

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1443

6040

2.70

224.90

2.0

1.6

—

(3001604) Monocytes [#/volume] in Blood

4244

28453

2.07

210.40

8.0

5.6

0.6

e9/l

12.86

3691

24150

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2174

11289

2.28

210.01

4.5

1.6

1.5

1.4

mg/l

0.71

1710

8808

(3033658) Prothrombin time (PT) actual/Normal

2669

15099

2.16

208.04

6.3

3.6

72.9

92.3

192.65

2608

14764

(3006315) Basophils [#/volume] in Blood

4252

28609

2.06

207.73

8.0

5.7

0.0

e9/l

0.44

3702

24318

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

935

3239

3.14

205.32

14.7

6.5

24.5

24.7

mmol/l

1.13

928

3209

(3013115) Eosinophils [#/volume] in Blood

4347

29574

2.05

204.88

8.5

5.9

0.2

e9/l

4.32

3814

25496

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

766

2366

3.48

202.75

1.8

1.5

1.6

g/l

0.77

663

2017

(3019198) Lymphocytes [#/volume] in Blood

4297

29304

2.03

198.87

8.1

5.7

1.8

2.0

e9/l

7.47

3787

25370

(3024354) Oxygen [Partial pressure] in Venous blood

1071

4126

2.85

193.93

5.3

3.0

4.6

4.5

kpa

0.09

1030

4006

(42870588) Differential panel, method unspecified - Blood

3193

19712

2.04

193.92

7.9

5.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

533

1327

4.24

192.20

5.2

2.6

3.6

g/l

0.01

508

1270

(3022096) Basophils/100 leukocytes in Blood

3910

26096

1.99

188.84

8.4

5.9

0.6

0.7

5.28

3733

24083

(3006504) Eosinophils/100 leukocytes in Blood

3977

26864

1.97

183.73

8.3

5.9

2.7

3.0

10.61

3799

24775

(3020630) Protein [Mass/volume] in Serum or Plasma

1168

4846

2.66

182.48

2.8

2.6

64.5

66.9

g/l

20.49

1082

4357

(3019069) Monocytes/100 leukocytes in Blood

3990

27030

1.97

182.25

8.6

6.2

9.1

8.8

5.58

3815

25021

(3027945) Reticulocytes/100 erythrocytes in Blood

1410

6431

2.45

180.39

2.6

2.4

1.9

1.7

7.92

1267

5622

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

632

1866

3.60

178.67

4.2

2.1

722.2

627.1

ug/l

0.14

610

1755

(3044889) 12 lead EKG panel

5557

42392

2.06

178.08

7.2

3.2

—

(40758558) Short blood count panel - Blood

2501

14504

2.06

176.80

8.9

7.0

—

(3021589) Normoblasts [#/volume] in Blood

3853

25971

1.95

176.73

13.6

8.9

0.0

e9/l

0.29

3166

21149

(3024561) Albumin [Mass/volume] in Serum or Plasma

3839

25892

1.94

175.28

6.2

4.7

34.1

35.4

g/l

38.09

3605

23889

(3003434) Protein [Mass/volume] in Pleural fluid

324

572

5.86

175.13

1.6

1.3

26.8

37.5

g/l

32.44

270

532

(3002030) Lymphocytes/100 leukocytes in Blood

4037

27749

1.94

173.50

8.4

6.0

24.2

27.7

75.67

3852

25540

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

507

1322

4.03

171.40

5.3

2.4

211.7

190.7

5.68

491

1255

(3018010) Neutrophils/100 leukocytes in Blood

3968

27313

1.92

167.76

8.3

5.8

60.4

57.1

53.54

3788

25289

(3042936) Bacteria identified in Isolate by Culture

1602

7950

2.28

167.72

2.7

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4614

33439

1.92

165.85

10.9

9.2

4.5

4.1

e9/l

18.96

4042

28916

(3036489) Thrombin time

602

1839

3.46

161.11

4.8

2.0

22.6

21.1

3.48

561

1607

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2852

17775

1.95

160.98

3.0

2.0

295.1

230.4

u/l

0.61

2713

16625

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

531

1495

3.74

160.78

6.4

2.1

87.7

91.1

2.81

515

1388

(3023199) Leukocytes [#/volume] in Pleural fluid

300

538

5.76

159.40

1.6

1.3

4389.2

3040.1

e6/l

0.16

205

392

(3024928) Oxygen saturation in Venous blood

399

918

4.53

158.95

5.3

3.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2603

15824

1.96

157.33

3.7

2.6

2449.5

5641.5

umol/l

5.35

2273

13588

(3028308) Erythrocytes [#/volume] in Pleural fluid

283

490

5.95

155.98

1.5

1.3

28879.5

63964.5

e6/l

1.98

171

298

(3012441) Differential panel - Pleural fluid

270

451

6.16

154.37

1.5

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

185

203

9.31

152.98

38.4

33.0

7.8

7.3

ug/l

1.46

172

182

(3045788) Cell count panel - Pleural fluid

256

409

6.44

152.98

1.6

1.4

—

(3019060) Gas panel - Arterial blood

860

3401

2.72

146.07

6.3

4.3

—

(3042733) HLA Ab [Presence] in Serum

156

144

11.03

146.00

4.5

4.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2865

18338

1.89

145.63

3.5

3.3

44.8

35.2

u/l

1.87

2701

17270

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

794

3022

2.81

145.15

18.3

8.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

414

1118

3.85

132.77

2.4

2.7

32.7

36.0

umol/l

1.44

357

950

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1295

6469

2.20

130.31

3.0

2.8

9.7

9.6

umol/l

0.06

1154

5691

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

393

1068

3.82

124.82

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

393

1068

3.82

124.82

1.4

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

884

3818

2.48

124.35

1.7

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5760

46853

1.86

123.21

11.0

7.3

82.5

79.4

u/l

4.12

5535

43782

(3030467) Casts [#/volume] in Urine by Automated count

2657

17301

1.81

122.84

3.8

3.1

0.8

0.4

e6/l

3.51

2087

12918

(36304419) Bacteria [Presence] in Urine

2571

16576

1.82

122.84

3.7

3.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

785

3233

2.59

121.98

5.3

2.9

128.4

130.0

g/l

0.98

761

3159

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

529

1789

3.10

119.06

4.2

3.2

45.7

44.2

mg/l

0.09

436

1485

(3034860) Kappa light chains.free [Mass/volume] in Serum

530

1795

3.09

118.98

4.3

3.2

52.7

77.3

mg/l

0.37

437

1491

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

516

1739

3.11

116.78

4.3

3.2

2.1

3.1

ratio

0.51

134

(3052851) Hemolysis interference index of Serum or Plasma

496

1636

3.17

116.44

5.0

3.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1110

5449

2.21

115.61

2.2

2.3

0.2

g/l

9.51

1023

5100

(3002582) Erythrocytes [#/volume] in Urine

2813

18895

1.76

115.22

3.9

3.2

84.9

91.5

e6/l

0.13

2236

14421

(3023520) Reticulocytes [#/volume] in Blood

1018

4853

2.26

113.80

2.7

2.4

73.9

66.4

e9/l

6.47

736

3682

(40768806) Pleura Pathology biopsy report

241

483

5.12

113.11

1.6

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1240

6428

2.10

112.05

2.4

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

216

402

5.50

110.13

1.3

6.7

5.5

mmol/l

4.66

203

363

(3022493) Free Hemoglobin [Mass/volume] in Plasma

149

189

8.02

109.68

30.8

1.2

74.4

1449.5

mg/l

0.52

133

126

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

281

664

4.35

107.87

8.8

5.9

11.1

11.4

mg/l

0.55

255

608

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

612

2377

2.71

106.54

4.8

2.5

0.6

0.7

1.99

598

2261

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

768

3343

2.44

105.47

1.8

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

157

222

7.20

105.14

23.9

26.4

118.3

115.8

ug/l

0.15

104

195

(3018095) Leukocytes [#/volume] in Urine

3060

21531

1.69

102.79

4.4

3.6

80.7

91.1

e6/l

0.37

2324

15397

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

864

4005

2.30

102.70

5.3

3.7

125.3

84.2

ng/l

18.72

782

3427

(3008152) Bicarbonate [Moles/volume] in Arterial blood

757

3333

2.41

101.19

9.9

6.1

24.3

24.5

mmol/l

0.83

721

3069

(3009445) Proteinase 3 Ab [Units/volume] in Serum

586

2329

2.64

97.22

1.3

1.6

10.2

20.9

u/ml

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

708

3088

2.42

96.48

1.6

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

279

714

4.01

96.24

1.5

1.2

3.3

3.4

u/ml

0.09

138

304

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

202

400

5.16

96.09

1.4

1.3

428.6

676.2

u/l

0.47

189

379

(3000850) Epithelial cells [#/volume] in Urine

2017

12865

1.76

95.31

3.0

2.5

4.7

4.4

e6/l

0.81

1815

11150

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

449

1572

2.97

94.72

2.7

2.3

0.0

g/l

0.00

409

1447

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

475

1718

2.88

94.46

2.6

2.2

0.0

0.1

g/l

1.89

433

1565

(40760888) Immunoglobulin light chains.free panel - Serum

399

1309

3.16

94.24

4.2

3.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

281

736

3.92

93.84

1.5

1.2

2.6

4.2

u/ml

0.66

101

240

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

444

1554

2.97

93.71

1.9

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

553

2178

2.66

93.34

2.6

2.2

10.0

10.2

g/l

0.43

482

1789

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

451

1601

2.93

92.77

2.7

2.3

0.0

g/l

0.03

409

1454

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

351

1077

3.36

92.51

9.9

5.0

925.1

2062.1

iu/ml

0.37

161

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

322

935

3.55

92.48

1.7

1.4

116.1

107.6

u/ml

1.10

187

(3004588) Protein electrophoresis panel - Serum or Plasma

853

4106

2.21

92.08

2.8

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

552

2196

2.63

91.27

2.7

2.3

3.2

3.0

g/l

3.13

466

1672

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1035

5386

2.06

91.20

2.6

2.5

58.3

64.9

u/l

0.10

891

4672

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

342

1049

3.36

90.17

1.7

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

2336

2.56

89.58

2.6

2.2

3.7

3.9

g/l

2.27

460

1632

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

2343

2.55

89.01

2.6

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

2345

2.55

88.85

2.6

2.2

7.3

7.4

g/l

0.29

469

1714

(3017143) Hepatitis C virus Ab [Presence] in Serum

998

5196

2.05

87.61

1.8

1.5

—

(3024932) HLA-DR beta [Type]

123

165

7.56

86.30

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

314

942

3.43

85.71

1.5

1.3

288.9

271.0

u/ml

0.50

235

586

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

479

1831

2.72

85.63

2.6

2.2

36.0

38.3

g/l

11.02

421

1527

(3027315) Oxygen [Partial pressure] in Blood

350

1124

3.21

85.60

5.8

3.3

8.2

8.7

kpa

5.94

344

1095

(3024471) HLA-A [Type]

123

167

7.47

85.40

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

473

1808

2.72

84.54

5.6

3.6

1.4

mmol/l

0.39

464

1780

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

504

1998

2.63

83.78

2.8

2.3

0.6

1.1

g/l

2.74

440

1680

(1616796) Gas panel - Central venous blood

347

1126

3.18

83.39

5.1

3.0

—

(3044640) Blood type and Crossmatch panel - Blood

2649

18699

1.63

83.24

3.2

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1207

6855

1.90

81.98

1.9

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

372

1274

3.02

81.47

5.3

3.0

8.2

8.3

kpa

0.70

352

1180

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

362

1223

3.05

81.19

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

1178

6670

1.90

80.65

1.3

467.7

518.0

titre

0.37

221

1349

(3026782) Osmolality of Urine

1869

12170

1.70

79.72

3.1

2.7

529.5

576.7

mosm/kgh2o

20.22

1637

10278

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

320

1018

3.23

79.45

1.5

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1048

5735

1.95

79.39

1.8

1.5

—

(3020891) Body temperature

505

2059

2.55

79.15

6.8

4.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1689

10721

1.73

78.97

3.2

2.8

1.2

1.1

e6/l

0.61

940

6155

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5064

41909

1.59

78.46

4.5

3.5

15.3

14.8

pmol/l

33.81

4686

37271

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

526

2198

2.49

78.25

2.2

1.8

4.5

2.2

ug/l

0.40

478

1941

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

351

1198

3.02

77.30

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

345

1169

3.04

76.94

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2107

14274

1.65

76.76

3.1

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

724

3512

2.17

76.04

5.3

3.2

2.0

1.5

mmol/l

2.18

521

2579

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

118

175

6.83

75.65

2.4

1.8

189.2

143.9

5.78

112

161

(3013290) Carbon dioxide [Partial pressure] in Blood

334

1123

3.06

75.49

5.9

3.3

4.9

5.0

kpa

1.26

328

1095

(3012501) Base excess in Blood by calculation

334

1123

3.06

75.49

5.9

3.3

2.6

2.4

mmol/l

0.85

221

739

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

750

3700

2.14

75.42

5.3

3.2

5.1

kpa

0.01

699

3392

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1598

10106

1.73

75.24

3.4

3.0

2.4

1.8

e6/l

1.77

851

5570

(3021879) Hepatitis B virus core Ab [Presence] in Serum

705

3414

2.17

74.31

1.5

1.4

—

(3035880) pH of Pleural fluid

133

228

5.92

73.98

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

12.78

73.36

1.4

1.2

4.1

521578.6

nmol/l

0.71

(3010421) pH of Blood

365

1311

2.87

73.29

5.8

3.2

7.4

0.52

328

1095

(3009343) pH of Capillary blood

737

3656

2.12

72.96

5.3

3.2

7.4

1.90

129

404

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

195

472

4.21

72.48

2.5

2.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

594

2710

2.29

72.39

4.7

2.9

25.0

mmol/l

0.19

573

2634

(40767503) Oxygen content in Capillary blood by calculation

321

1083

3.05

72.10

3.1

2.3

16.3

16.8

1.01

173

598

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

396

1498

2.73

72.08

1.5

12.8

15.1

iu/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

251

729

3.52

71.99

1.4

1.1

95.0

118.6

16.61

246

651

(4306422)

252

739

3.49

71.22

1.4

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

399

1526

2.70

71.07

6.1

3.8

4.0

3.9

mmol/l

4.79

380

1438

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

255

759

3.44

70.42

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

190

461

4.20

70.40

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

160

340

4.78

70.08

1.3

1.2

11.0

16.1

u/l

1.02

142

323

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

445

1816

2.54

69.47

1.5

1.6

140.0

247.2

titre

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

119

196

6.15

68.94

6.5

1.4

21.7

801.3

ug/l

1.30

114

176

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

136

258

5.35

67.90

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

395

1541

2.65

67.61

1.3

1.2

—

(4268621)

189

476

4.04

66.61

2.9

2.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

214

592

3.69

66.03

2.0

1.7

89.6

89.7

0.10

209

583

(3021901) Oxygen saturation in Capillary blood

289

967

3.06

65.83

3.6

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

293

990

3.04

65.62

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4671

38763

1.51

64.69

5.1

4.2

1431.8

1724.1

e6/l

0.13

579

(3048929) Epstein Barr virus Ab [Presence] in Serum

365

1410

2.67

63.68

1.5

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

451

1932

2.42

63.33

2.4

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1021

5938

1.83

63.08

4.4

3.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

358

1380

2.67

62.72

1.4

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

334

1243

2.76

62.67

2.5

2.0

131.0

131.3

g/l

0.07

227

889

(3014148) Varicella zoster virus Ab [Titer] in Serum

191

510

3.81

62.04

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

357

1391

2.64

61.20

4.1

2.6

24.2

24.6

mmol/l

0.58

320

1217

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

266

885

3.08

61.18

1.6

1.7

—

(3026008) Bacteria identified in Urine by Culture

2287

16535

1.54

60.38

3.2

3.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2501

18438

1.52

60.30

3.0

2.5

61.4

59.7

u/l

0.45

2346

16915

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

375

1512

2.55

59.94

5.7

3.9

1.9

1.4

mg/l

17.65

348

1378

(3028271) Lactate [Moles/volume] in Capillary blood

244

785

3.18

59.41

2.2

1.7

mmol/l

0.10

239

770

(3024891) Influenza virus A+B Ag [Presence] in Specimen

322

1218

2.71

58.52

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

144

328

4.45

57.93

6.9

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3476

27586

1.47

57.36

4.7

3.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

249

834

3.05

56.61

4.6

3.0

3920.7

10693.1

u/ml

0.35

(3028026) IgM [Mass/volume] in Serum or Plasma

610

3094

2.05

56.43

2.0

1.9

1.2

1.4

g/l

0.60

567

2782

(3034426) Prothrombin time (PT)

160

6.13

56.14

1.5

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

160

411

3.95

54.91

1.1

1.2

92.0

169.2

titre

1.30

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

219

694

3.22

54.69

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

9.00

54.52

1.6

1.2

82.5

82.6

0.01

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

194

575

3.43

53.94

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

733

4023

1.91

53.94

2.7

2.6

10.2

10.6

g/l

1.35

685

3645

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

332

1337

2.55

53.16

1.4

0.2

g/l

0.54

310

1260

(3021960) Folate [Moles/volume] in Serum or Plasma

1974

14149

1.53

52.92

1.7

1.5

19.2

20.2

nmol/l

2.59

1769

11927

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

341

1395

2.51

52.82

1.4

1.2

g/l

0.52

321

1316

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.95

51.88

1.5

1.2

80.5

66.2

1.46

(3051611) Lipemic interference index of Serum or Plasma

195

599

3.31

51.24

6.4

3.0

—

(44790049)

183

543

3.43

50.81

1.6

1.4

—

(44790047)

183

543

3.43

50.81

1.6

1.4

—

(44790048)

183

543

3.43

50.81

1.6

1.4

—

(44806118)

183

543

3.43

50.81

1.6

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

189

578

3.33

50.02

2.5

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

245

872

2.87

49.97

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

804

4662

1.81

49.49

2.4

382.0

371.5

nmol/l

0.68

762

4305

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

505

2511

2.08

49.14

5.2

3.5

46.2

47.2

0.41

499

2481

(3009871) Measles virus Ab [Titer] in Serum

152

5.84

48.62

1.2

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

184

570

3.28

47.71

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5935

53017

1.49

47.64

5.5

4.2

2.1

2.2

mu/l

0.70

5533

47317

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

7.96

47.21

6.2

6.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

160

5.61

47.16

2.7

1.7

12742.6

2354.8

e6/l

0.86

(3002385) Erythrocyte distribution width [Ratio]

5555

49066

1.45

46.58

34.5

15.8

14.2

13.7

112.88

5470

47859

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

11.81

46.28

4.4

3.5

70.4

57.3

1.02

(3013707) Erythrocyte sedimentation rate by Westergren method

5040

43785

1.42

45.89

5.1

3.9

15.3

12.0

mm/h

33.51

4723

40010

(3037756) Immunofixation for Serum or Plasma

293

1197

2.50

45.50

1.7

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

776

4618

1.75

43.47

3.4

2.5

52.5

67.4

ml/min/173m2

22.98

348

1753

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6544

59989

1.54

43.29

28.4

12.6

25.7

26.6

mg/l

1.44

5808

46881

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

132

351

3.81

43.21

1.7

1.3

13.4

11.7

u/l

2.29

127

339

(3012516) Albumin [Mass/volume] in Urine

2501

19388

1.43

43.13

3.5

3.2

362.6

346.6

mg/l

0.07

1800

12376

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.97

42.12

5.9

7.1

—

(3009508) Creatinine [Moles/volume] in Urine

2576

20148

1.41

41.96

3.4

3.2

7.2

8.0

mmol/l

21.21

2178

16763

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

139

5.66

41.75

1.4

1.3

61.8

56.8

0.47

122

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

193

666

2.95

41.67

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

209

759

2.80

41.08

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3148

25562

1.39

40.80

2.2

2.0

91.5

94.1

pmol/l

2.37

1733

13499

(3023487) Leukocytes [#/volume] in Peritoneal fluid

191

4.81

40.55

2.8

1.9

622.4

3683.6

e6/l

0.63

135

(3000492) Spirometry study

833

5186

1.68

39.40

1.6

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

232

908

2.60

39.40

1.2

1.4

30.6

32.6

u/l

0.10

213

769

(3015377) Calcium [Moles/volume] in Serum or Plasma

2565

20220

1.40

39.28

3.7

3.5

2.3

2.4

mmol/l

6.13

2217

17406

(3007164) IgA [Mass/volume] in Serum or Plasma

1368

9591

1.52

39.04

1.6

1.4

2.6

g/l

0.46

864

5582

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

705

2.81

38.67

1.3

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2577

20482

1.38

37.03

4.2

4.0

15.4

6.8

mg/mmol

10.57

1803

13099

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

286

1271

2.30

36.81

1.4

1.5

—

(3013512) EKG study

2257

17576

1.40

36.55

6.6

3.3

—

(3022313) Gas panel - Capillary blood

497

2726

1.88

36.26

5.9

3.3

—

(3033799) Differential panel - Peritoneal fluid

170

4.80

36.13

2.6

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

130

5.42

35.88

1.7

1.4

18.4

10.5

g/l

9.49

(3002331) Protein [Mass/volume] in Peritoneal fluid

116

5.73

35.87

1.7

1.4

31.5

34.3

g/l

0.08

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

35.43

2.2

0.0

—

(3047189) Immunofixation for 24 hour Urine

102

264

3.90

34.75

2.0

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

6.92

34.69

1.3

52.3

232.3

ng/l

1.12

(3001893) Eosinophils/100 leukocytes in Pleural fluid

125

5.40

34.18

1.3

2.9

3.2

0.10

111

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

20.89

32.92

1.4

1.0

127.8

186.4

ug/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

128

5.19

32.27

6.3

5.2

25.4

24.7

mmol/l

0.64

120

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

100

271

3.72

31.94

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

100

271

3.72

31.94

1.2

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1566

11669

1.43

31.93

1.8

1.7

1225.6

1119.0

nmol/l

4.14

1243

8576

(3014765) Yersinia sp identified in Stool by Organism specific culture

305

1492

2.09

30.90

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

112

336

3.37

30.69

1.5

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

305

1499

2.08

30.52

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

165

4.46

29.80

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

300

1481

2.07

29.67

1.3

1.2

—

(3014891) Appearance of Pleural fluid

9.25

29.12

2.0

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6769

63579

1.47

29.12

38.3

14.3

139.3

139.7

mmol/l

28.29

6673

61726

(3035947) Staphylolysin Ab [Units/volume] in Serum

230

3.81

28.83

1.2

1.1

3.3

2.7

iu/ml

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4643

41198

1.31

28.68

4.9

4.1

—

(3044007) Cell count panel - Peritoneal fluid

156

4.45

28.17

3.3

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

311

1587

2.00

28.08

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

148

552

2.71

27.75

3.5

3.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1739

13468

1.37

27.71

3.9

3.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

21.05

27.65

3.1

8.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

7.90

27.22

1.4

14.8

13.6

0.06

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

196

844

2.36

27.20

1.2

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6772

63791

1.45

26.94

38.7

14.4

4.1

4.0

mmol/l

91.53

6670

61830

(3025941) Bacteria identified in Stool by Culture

473

2807

1.73

26.43

1.4

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

120

4.86

26.38

1.4

1.2

23.5

23.8

0.02

112

(3021788) Differential panel - Synovial fluid

225

1041

2.20

26.34

1.4

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

277

1391

2.03

26.17

1.2

139.2

105.2

titre

0.26

118

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

148

569

2.63

26.17

1.6

—

(3023419) Bacteria identified in Sputum by Culture

165

672

2.49

25.90

2.0

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1456

11072

1.39

25.70

3.0

3.3

2.5

mmol/l

2.34

1243

9706

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

413

2378

1.78

25.64

7.3

4.5

1.7

1.6

1.30

389

2230

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

222

1033

2.18

25.63

1.6

1.7

52.2

4.1

iu/l

0.48

338

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

529

2.68

25.63

1.6

1.7

—

(3003181) Sodium [Moles/volume] in Urine

211

966

2.22

25.36

1.5

1.3

59.7

65.0

mmol/l

1.00

163

777

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

103

5.08

24.88

1.4

1.3

25.1

23.3

0.15

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

159

4.18

24.87

1.2

1.1

—

(3004451) EKG impression Narrative

199

3.80

24.77

1.1

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2741

22977

1.30

24.66

2.6

2.1

75.5

77.9

nmol/l

4.24

2481

20220

(21494755) Public health laboratory ask at order entry panel

237

4576

0.50

24.26

1.3

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

412

2409

1.75

24.25

6.4

3.4

24.6

24.7

mmol/l

0.15

390

2212

(3007930) Methemoglobin/Hemoglobin.total in Blood

403

2342

1.76

24.24

7.4

4.5

0.9

1.24

380

2197

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

113

403

2.83

23.14

1.4

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

727

4945

1.52

23.14

5.3

3.4

1.2

mmol/l

11.12

671

4244

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

277

3.24

23.09

1.2

32.7

23.0

u/l

1.21

230

(3047181) Lactate [Moles/volume] in Blood

312

1708

1.86

22.87

8.6

5.3

1.4

1.3

mmol/l

2.04

283

1491

(40760892) CBC W Ordered Manual Differential panel - Blood

1532

11941

1.35

22.82

5.7

4.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

120

446

2.72

22.73

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

120

446

2.72

22.73

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

120

446

2.72

22.73

1.6

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

6.96

22.44

1.3

1.2

59.3

716.9

u/l

0.65

(3042631) Mycobacterium sp identified in Specimen

175

785

2.26

22.15

2.2

2.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

202

3.59

21.97

1.9

2.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

6.34

21.78

1.3

1.1

1.3

2.3

mmol/l

0.37

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

6.90

21.60

1.5

1.2

65.8

71.4

0.33

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

117

4.47

21.43

1.1

1.2

64.4

87.1

3.31

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

285

3.11

21.40

1.2

115.2

88.1

u/l

1.32

241

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.20

21.21

1.3

1.1

1.4

2.1

mmol/l

2.48

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

115

4.46

20.96

1.1

1.2

58.0

88.3

3.93

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

194

928

2.12

20.94

1.2

—

(1761868) Lipid panel - Serum or Plasma

1646

20330

0.76

20.90

3.2

3.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

249

4521

0.54

20.86

1.6

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

114

441

2.61

20.01

1.4

1.1

—

u/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

119

473

2.54

19.76

1.5

1.3

54.6

26.2

iu/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

187

903

2.10

19.72

4.9

2.8

—

(3044941) Cell count panel - Synovial fluid

181

879

2.08

18.82

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.78

18.80

7.4

7.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6118

57479

1.29

18.69

28.0

12.1

71.8

79.3

ml/min/173m2

108.01

5493

46854

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4204

37857

1.24

18.59

3.7

3.0

73.9

52.1

u/l

24.41

3913

34752

(3023383) Lactate [Moles/volume] in Pleural fluid

131

3.99

18.54

1.4

1.2

2.7

4.4

mmol/l

3.78

126

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

384

2372

1.65

18.46

2.1

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6032

56649

1.28

17.97

7.0

5.9

42.2

40.1

mmol/mol

36.85

5676

51715

(3000475) Leukocytes [#/volume] in Synovial fluid

254

1410

1.83

17.87

1.7

1.6

17047.8

12069.3

e6/l

0.76

171

1019

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

122

516

2.39

17.77

1.2

82.9

70.7

u/l

0.18

333

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

891

6627

1.39

17.44

1.8

1.6

1.5

3.72

746

5777

(3042111) Morphology [Interpretation] in Bone marrow Narrative

195

1010

1.95

16.99

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

359

2228

1.64

16.95

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

293

1737

1.71

16.47

5.6

1.4

6.5

3.9

mg/l

2.32

262

1221

(3040151) Glucose [Moles/volume] in Capillary blood

138

636

2.19

16.46

9.9

6.0

7.1

7.5

mmol/l

0.86

117

536

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

2192

1.62

15.95

1.9

1.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.15

15.90

1.0

16.1

25.1

u/l

0.96

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

340

2.61

15.58

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

291

2.73

15.37

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

291

2.73

15.37

1.3

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.43

15.35

1.3

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

210

3.06

15.34

13.6

3.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

136

642

2.14

15.31

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

168

858

1.98

15.29

1.6

0.8

0.9

g/l

0.85

126

651

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

156

777

2.03

15.23

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

1025

7954

1.33

15.16

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

255

2.84

15.08

2.6

2.1

—

(3018572) Chloride [Moles/volume] in Blood

220

1234

1.81

15.02

10.5

6.2

104.5

105.2

mmol/l

1.14

202

1104

(3039000) Anion gap in Blood

220

1234

1.81

15.02

10.5

6.2

12.0

11.3

mmol/l

2.04

202

1104

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

152

2904

0.51

15.01

1.3

1.5

—

(3000494) Fungus identified in Specimen by Culture

900

6877

1.35

14.75

1.6

1.4

—

(3037121) Protein [Mass/volume] in Urine

323

2026

1.62

14.65

2.7

3.4

0.4

0.3

g/l

0.74

168

936

(3019977) pH of Arterial blood

288

2.69

14.56

2.4

2.2

7.4

0.19

110

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

115

519

2.23

14.50

3.2

2.7

—

(40761511) CBC panel - Blood by Automated count

6550

62564

1.28

14.45

25.4

12.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

293

1800

1.65

14.44

1.2

0.3

0.9

u/ml

1.42

174

(3036603) Volume of Urine

367

2.47

14.29

1.6

1.7

1803.8

2047.2

0.60

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.30

14.25

3.7

6.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

146

729

2.02

14.19

1.3

0.7

0.9

nmol/l

0.22

139

705

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

405

2.39

14.16

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

146

731

2.02

14.08

1.3

0.3

0.4

nmol/l

0.49

(3044242) Glucose [Moles/volume] in Arterial blood

256

2.75

13.84

2.4

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1096

8703

1.30

13.65

1.2

40.6

38.1

iu/ml

0.17

311

2651

(3017181) Myelocytes/100 leukocytes in Blood

681

5042

1.38

13.60

4.6

3.9

0.8

1.0

1.77

251

1417

(3021601) Nitrite [Presence] in Urine by Test strip

3207

28646

1.20

13.59

5.4

4.7

0.0

estimate

0.80

678

5194

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

135

667

2.04

13.53

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

179

974

1.86

13.52

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

3197

28566

1.20

13.45

4.1

3.4

0.0

estimate

0.50

660

5082

(44816559) Phosphatidylethanol [Mass/volume] in Blood

178

970

1.85

13.39

1.3

—

(4035726)

742

5585

1.36

13.37

2.0

1.3

—

(40761535) Cells panel - Urine sediment

668

4955

1.38

13.19

4.0

3.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

369

2.40

13.18

1.9

2.2

—

(3025315) Body weight

6.58

13.18

4.8

3.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.58

13.18

3.2

3.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2227

25514

0.82

13.09

3.8

4.4

22.7

21.9

1.46

1002

13130

(4010399)

580

4215

1.41

12.93

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

114

546

2.10

12.45

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

3226

29008

1.19

12.27

4.1

3.5

0.0

estimate

1.87

632

4995

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

109

3.59

12.11

1.2

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

5.23

11.99

1.1

1.3

22.4

33.1

0.53

(3027135) IgG subclass 1 [Mass/volume] in Serum

109

521

2.11

11.98

1.4

1.3

7.5

6.9

g/l

0.58

363

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

425

2.23

11.88

1.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

350

2.36

11.85

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.85

11.78

1.0

1.1

—

(4062490)

108

519

2.10

11.72

1.4

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2860

31802

0.84

11.67

4.2

5.2

2.7

3.5

ug/l

2.49

2503

28567

(3024139) IgG subclass 3 [Mass/volume] in Serum

108

521

2.09

11.60

1.4

1.3

0.5

0.4

g/l

0.88

361

(3028192) IgG subclass 2 [Mass/volume] in Serum

108

521

2.09

11.60

1.4

1.3

2.9

3.0

g/l

0.33

365

(3021440) Promyelocytes/100 leukocytes in Blood

637

4799

1.36

11.39

4.6

4.0

0.1

0.81

227

1315

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

214

2.72

11.35

1.4

2.3

68.6

144.0

umol/l

2.29

113

(40757494) Bilirubin.total [Moles/volume] in Blood

272

2.51

11.33

1.8

2.1

22.2

45.3

umol/l

—

(21494815) CD4 cells/100 lymphocytes in Specimen

101

480

2.12

11.29

1.8

2.2

32.2

39.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

609

4568

1.36

11.20

4.5

3.8

0.6

0.7

0.47

183

1028

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.25

11.04

2.7

1.9

74.2

54.1

1.45

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

294

2.43

11.01

2.1

1.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.91

11.00

2.6

3.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.76

10.99

1.1

1.2

0.9

0.6

umol/24h

0.89

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

395

2.22

10.92

1.7

2.1

14.0

14.9

0.14

173

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1302

10831

1.24

10.85

1.2

1.3

1.9

2.1

u/ml

0.13

312

2738

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

186

2.81

10.81

1.6

1.9

730.8

52406.2

u/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

108

3.44

10.80

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

279

2.45

10.76

1.1

ratio

0.50

(3045716) Anion gap in Serum or Plasma

251

2.52

10.61

2.7

2.1

9.0

9.5

mmol/l

0.47

192

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

636

1.93

10.60

1.3

—

nmol/l

—

(3016038) Potassium [Moles/volume] in Urine

368

2.24

10.60

1.3

1.2

36.2

mmol/l

0.00

312

(3001964) Herpes simplex virus Ag [Presence] in Specimen

156

2.96

10.53

1.2

1.5

—

(40761536) Microorganisms panel - Urine sediment

624

4744

1.34

10.50

4.3

3.7

—

(3017704) Immunofixation for Urine

305

2.34

10.18

1.9

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

149

841

1.79

10.11

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

162

940

1.74

10.00

1.2

1.3

222.1

207.2

miu/ml

0.16

387

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.53

9.74

2.4

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

152

873

1.76

9.73

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

141

794

1.79

9.66

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.57

9.63

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5993

57314

1.19

9.63

4.8

4.0

1.4

1.3

mmol/l

15.15

5590

51501

(3011412) CD3 cells [#/volume] in Blood

100

504

2.00

9.62

2.2

2.4

1.1

e9/l

0.27

300

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

276

2.37

9.59

3.5

4.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.01

9.55

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

112

3.22

9.55

1.5

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

119

638

1.88

9.55

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

365

2585

1.43

9.46

1.4

1.6

—

(3025159) Blasts/100 leukocytes in Blood

589

4512

1.33

9.42

4.7

3.9

0.0

0.4

1.78

194

1104

(3029937) Albumin [Presence] in Urine by Test strip

1776

15431

1.19

9.40

4.6

3.8

0.0

estimate

0.09

621

4928

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

247

1621

1.54

9.35

2.2

2.3

117.2

103.0

ug/min

0.26

136

993

(3039443) Prostate specific Ag panel - Serum or Plasma

1647

0.50

9.34

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

269

2.35

9.20

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

269

2.35

9.20

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

269

2.35

9.20

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

269

2.35

9.20

1.7

1.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

225

1458

1.56

9.03

1.5

1.7

—

(3044927) Protein electrophoresis panel - Urine

112

603

1.87

8.90

1.4

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3483

32048

1.16

8.88

2.7

2.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

331

2.19

8.85

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

331

2.19

8.85

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.32

8.85

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

332

2.18

8.79

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

392

2.08

8.74

1.0

1.1

304.6

279.4

mg/l

2.06

352

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

335

2.16

8.60

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

335

2.16

8.60

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

335

2.16

8.60

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

164

2.69

8.54

1.7

1.6

9.3

9.5

ug/l

0.11

164

(3005322) IgE [Units/volume] in Serum or Plasma

405

2978

1.38

8.47

1.4

1.3

209.9

300.6

u/ml

1.74

385

2747

(3037692) Legionella sp identified in Specimen by Organism specific culture

182

2.59

8.47

1.1

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.34

8.46

1.2

1.3

64.4

278.2

titre

—

(21494434) Karyotype in Bone marrow

101

536

1.90

8.42

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

5661

54080

1.17

8.36

33.2

14.0

39.6

39.9

1.84

3933

37160

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.87

8.35

2.9

1.8

5.5

24.1

2.09

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

202

1303

1.56

8.31

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

144

2.79

8.30

2.0

2.4

236.7

553.0

e6/l

0.52

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

648

8075

0.78

7.87

5.0

4.6

31.9

32.0

0.10

503

5172

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6700

65008

1.21

7.86

35.9

15.0

96.2

80.0

umol/l

123.29

6693

64976

(40768446) Kidney Pathology biopsy report

208

2.41

7.79

1.8

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

125

731

1.72

7.61

1.6

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

127

746

1.71

7.61

1.1

1.7

1.5

g/l

5.81

122

667

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

127

746

1.71

7.61

1.4

1.5

68.0

56.8

2.56

463

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.66

7.44

1.2

1.1

—

(3003338) MCHC [Mass/volume]

5283

50377

1.15

7.40

38.7

16.6

330.2

333.3

g/l

109.01

5223

49962

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

971

8137

1.22

7.39

1.2

13.4

14.8

u/ml

0.23

341

2987

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

131

2.76

7.36

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

121

711

1.71

7.26

1.3

1.4

—

(3024263) Appearance of Synovial fluid

313

2.09

7.18

1.4

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

100

3.01

7.17

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

111

2.89

7.14

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

553

1.80

7.09

1.3

1.7

1.4

nmol/l

2.07

501

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

681

1.71

7.00

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

227

1568

1.46

6.82

1.4

1.6

0.4

5.9

iu/ml

0.87

341

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

190

1266

1.51

6.82

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

131

2.68

6.81

1.1

—

(40768800) Prostate Pathology biopsy report

144

2240

0.64

6.75

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

211

2.28

6.66

3.8

2.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

361

1.95

6.45

2.3

2.6

481.9

536.3

e6/l

0.27

295

(3028433) Virus identified in Specimen by Culture

190

2.32

6.38

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.84

6.25

5.6

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

262

1890

1.40

6.24

1.7

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

324

1.98

6.23

1.7

1.5

5.6

6.0

u/l

0.06

149

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1659

18543

0.87

6.14

2.7

3.1

0.8

ug/l

0.01

1176

12708

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

137

871

1.58

6.11

1.2

51.6

40.0

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

2.77

6.03

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

456

1.81

6.02

1.4

1.6

32.6

25.3

u/ml

—

109

(3011985) Renin [Units/volume] in Plasma

117

720

1.63

5.98

1.3

1.5

68.7

54.1

mu/l

0.35

105

645

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.82

5.96

1.7

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

380

1.88

5.89

2.7

2.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.01

5.89

1.0

1.3

2.1

1.6

umol/24h

0.62

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

381

1.87

5.85

2.2

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

227

1617

1.42

5.84

1.5

1.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

107

2.72

5.84

2.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

218

2.16

5.79

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

218

2.16

5.79

1.7

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

186

2.26

5.78

1.4

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

141

918

1.55

5.70

1.8

1.9

20.3

24.6

ug/l

0.77

136

901

(3047007) Chlamydophila sp Ab [Presence] in Serum

108

661

1.64

5.66

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

519

6388

0.80

5.65

2.4

2.1

12.3

12.8

nmol/l

0.64

453

5647

(3049717) Cytology report of Urine Cyto stain

369

2851

1.31

5.65

2.6

2.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

466

1.77

5.63

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

111

687

1.62

5.57

1.2

1.4

323.5

314.9

pmol/l

0.05

522

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

345

1.89

5.56

2.4

2.6

0.2

e9/l

1.02

293

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

417

1.81

5.55

2.1

2.4

437.8

609.2

e6/l

1.16

154

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.24

5.52

1.5

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.49

5.50

1.2

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.90

5.45

1.3

1.0

95.0

101.3

0.37

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

218

2.12

5.39

1.8

2.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

236

1721

1.38

5.33

1.3

1.4

257.3

263.0

ug/g

0.17

158

1040

(3049233) Organic acids panel - Urine

11.26

5.28

1.1

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

162

2.29

5.26

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

345

1.86

5.24

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

346

1.86

5.20

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

209

2.11

5.15

1.2

1.1

11.4

4.6

u/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

170

2.24

5.14

1.7

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

369

1.82

5.14

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

183

2.19

5.14

1.9

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

139

2048

0.67

5.11

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

140

2.36

5.05

1.2

19.4

569.3

ug/l

1.67

(4281824)

506

1.69

5.00

1.5

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

150

1021

1.48

4.97

3.2

3.5

1.6

1.5

0.09

124

776

(3014051) Protein [Presence] in Urine by Test strip

180

1270

1.43

4.95

2.3

2.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

334

1.83

4.79

2.0

2.7

39.4

35.6

0.53

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.00

4.77

1.0

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.00

4.77

1.0

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.74

4.76

1.3

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

178

1271

1.41

4.61

1.2

28.4

38.8

u/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

192

1389

1.39

4.61

4.5

2.6

1.6

mmol/l

0.04

185

1357

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

346

1.80

4.60

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

339

1.81

4.59

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

543

1.63

4.55

1.3

1.5

22.9

31.2

1.67

322

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.56

4.53

1.8

1.7

—

(3002619) Bacteria identified in Specimen by Culture

110

2.46

4.53

2.0

1.2

—

(3008295) Osmolality of Serum or Plasma

575

1.61

4.52

1.4

275.4

282.0

mosm/kgh2o

1.69

449

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

378

1.75

4.50

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

194

2.07

4.48

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.41

4.46

1.1

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6640

64941

1.14

4.45

15.8

9.9

28.8

27.0

u/l

4.62

6451

62160

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

321

1.81

4.43

2.3

73.2

156.7

ug/min

0.59

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.93

4.43

1.9

0.9

1.6

mmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

225

1.96

4.28

1.4

1.7

3.3

18.5

nmol/l

0.78

184

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

327

1.78

4.19

1.8

1.5

9.5

5.8

u/l

0.55

271

(3010144) Erythrocytes [#/volume] in Synovial fluid

563

1.59

4.19

1.6

1.3

166097.2

95116.3

e6/l

0.35

375

(1617658) Protocol used for examination of sentinel lymph nodes

341

0.29

4.17

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.91

4.16

1.3

1.8

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

4.08

4.15

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

143

1003

1.43

4.13

1.2

4.1

u/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

4.35

4.08

1.1

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

390

1.70

4.06

1.3

693.8

604.7

titre

—

(36660697) Celiac disease serology panel - Serum

475

3943

1.22

4.04

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

104

689

1.52

4.01

3.6

3.8

—

(3003694) ABO and Rh group [Type] in Blood

1740

15936

1.12

3.99

1.4

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

275

1.82

3.94

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

151

2.12

3.88

2.7

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

151

2.12

3.88

2.7

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

480

1.61

3.88

1.3

1.4

1.1

1.3

promille

0.64

383

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

636

0.50

3.86

1.3

104.2

108.5

pmol/l

0.03

208

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6149

59995

1.11

3.79

5.2

4.4

4.2

4.6

mmol/l

183.08

5796

54747

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6098

59476

1.11

3.76

5.1

4.4

1.3

1.4

mmol/l

140.14

5717

53890

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

288

1.78

3.71

3.4

3.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

894

7898

1.15

3.64

15.2

6.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.67

3.63

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

7.78

3.55

11.7

5.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

301

3725

0.80

3.54

1.4

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

178

1335

1.34

3.50

4.8

2.7

7.4

7.7

mmol/l

0.93

172

1309

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.55

3.48

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.66

3.39

1.4

1.3

—

mmol/l

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.00

3.36

3.0

5.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

3.36

2.9

4.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

296

2392

1.25

3.31

2.6

3.7

2327.2

1849.5

u/ml

0.11

244

2104

(21494814) CD8 cells/100 lymphocytes in Specimen

211

1.85

3.29

1.6

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

249

1.77

3.22

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

249

1.77

3.22

1.3

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

108

758

1.43

3.20

3.6

1.9

—

(3045414) Leukocytes [Presence] in Urine

316

2589

1.23

3.13

2.0

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.41

3.13

1.3

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

422

1.57

3.07

1.5

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

160

1208

1.33

3.06

1.2

5.8

6.1

u/ml

0.05

191

(3016135) IgD [Mass/volume] in Serum

5.84

3.02

4.4

1.2

35.0

81.6

mg/l

—

(4034850)

239

1907

1.26

3.01

18.4

8.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.00

2.96

1.1

—

(3022145) Colonoscopy Study observation

767

6805

1.14

2.96

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

167

1277

1.31

2.94

2.2

1.8

1.2

0.8

nmol/l

5.23

142

1060

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

121

2.07

2.91

2.0

2.6

8.2

7.7

mmol/l

0.19

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6270

61454

1.10

2.90

5.8

4.9

2.4

2.7

mmol/l

127.65

5890

55797

(3048879) Bone marrow aspiration report

184

1.85

2.90

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

109

2.11

2.83

1.6

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

238

1.73

2.80

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.40

2.79

1.5

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

2.26

2.76

1.7

1.1

—

(3018291) Platelet Ab [Presence] in Serum

8.34

2.75

1.2

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

270

1.67

2.73

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.00

2.72

1.7

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

156

1196

1.31

2.72

1.2

5.8

3.2

u/ml

0.46

118

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

6.00

2.69

1.3

1.1

1826.7

2016.7

umol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6067

59434

1.09

2.68

5.3

4.7

6.3

6.0

mmol/l

38.08

5581

53463

(3013336) Amino acids [Identifier] in Serum or Plasma

4.67

2.59

1.3

2.1

—

(40757373) Influenza virus identified in Isolate

101

2.08

2.52

1.2

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

525

0.57

2.51

1.0

298.6

330.0

ng/l

0.22

358

(3019897) Erythrocyte distribution width [Ratio] by Automated count

548

0.58

2.47

3.0

2.9

13.3

13.2

0.22

540

(3048689) Calprotectin [Mass/mass] in Stool

676

6040

1.13

2.38

1.9

2.3

137.0

150.8

ug/g

0.48

530

4722

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

527

0.59

2.35

1.0

34.0

42.5

ng/l

0.75

354

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

314

1.56

2.34

1.9

1.8

1.5

2.9

u/field

1.16

219

(40768443) Skin Pathology biopsy report

318

2692

1.19

2.33

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

252

1.63

2.32

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

525

0.59

2.32

1.0

722.4

731.6

ng/l

0.04

346

(3017354) Segmented neutrophils/100 leukocytes in Blood

653

1.38

2.31

3.0

3.6

64.3

57.1

2.40

411

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.22

2.30

3.7

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

348

2973

1.18

2.30

1.7

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

438

1.46

2.27

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

317

1.55

2.26

3.4

2.8

—

(3000012) Reticulocyte production index

334

1.53

2.23

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

683

1.37

2.23

1.8

2.3

876.7

2583.4

u/l

1.22

238

(3020961) Endomysium IgA Ab [Titer] in Serum

266

2226

1.20

2.23

1.1

57.2

228.8

titre

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.56

2.21

6.0

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

372

3218

1.16

2.13

2.5

2.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

335

2879

1.17

2.09

1.2

142.9

133.2

iu/ml

0.14

101

1016

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

152

1209

1.26

2.08

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

4.00

2.04

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.63

2.00

6.5

5.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

141

1.78

1.96

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.03

1.95

1.1

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.55

1.94

1.0

—

(4198724)

187

1.66

1.93

1.8

2.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

121

1.82

1.87

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

149

1840

0.81

1.87

5.1

3.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

277

1.52

1.83

1.2

1.5

—

(3019174) dRVVT (LA screen)

2.50

1.83

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.92

1.79

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

304

1.48

1.76

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

373

3282

1.14

1.74

1.8

1.9

—

(3007463) Buprenorphine [Presence] in Urine

3.85

1.71

1.4

10.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

307

0.55

1.69

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

307

0.55

1.69

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

307

0.55

1.69

1.2

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.68

0.0

1.8

—

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

306

0.55

1.67

1.2

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

329

0.58

1.63

1.3

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.57

1.61

7.8

6.2

550.6

437.1

umol/l

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

4.8

6.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

386

3427

1.13

1.60

1.2

1.3

32.4

57.9

au/ml

1.73

163

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

129

1.71

1.56

1.4

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

264

1.48

1.55

1.1

82.5

91.1

u/l

0.37

202

(3034274) Bile acid [Moles/volume] in Serum --fasting

297

1.45

1.55

1.7

2.4

5.3

13.9

umol/l

1.86

210

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

265

1.47

1.52

1.1

19.2

30.6

u/l

1.04

189

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

809

1.26

1.52

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

589

1.31

1.51

3.1

2.9

—

(3022621) pH of Urine by Test strip

435

3908

1.12

1.50

2.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

257

0.54

1.50

1.1

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

521

1.33

1.48

1.3

—

(3005033) Fetal Nuchal fold Thickness US

256

0.55

1.48

1.1

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.50

1.45

1.3

1.2

—

(4212803)

2.12

1.44

1.2

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.92

1.43

1.4

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

286

1.44

1.42

1.2

1.5

3.5

3.4

0.03

(4024509)

543

0.70

1.42

1.3

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

2.25

1.40

1.4

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

263

0.57

1.39

1.3

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.94

1.38

1.0

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

119

1.68

1.37

2.0

5.1

64.2

66.4

u/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

121

0.41

1.37

1.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

697

1.27

1.35

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

697

1.27

1.35

1.3

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.87

1.34

1.5

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.87

1.34

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.87

1.34

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

166

1407

1.18

1.33

1.2

1.3

—

(3016750) Collection duration of Urine

375

1.36

1.33

2.0

2.1

504.9

497.6

min

0.20

286

(3005988) Vibrio sp identified in Specimen by Organism specific culture

700

1.26

1.32

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

1.65

1.30

1.3

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

122

1.64

1.27

1.4

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

319

1.38

1.26

1.4

—

(40768795) Lymph node Pathology biopsy report

598

1.27

1.25

1.2

—

(3004775) Volume in Urine collected for unspecified duration

545

1.29

1.25

2.1

2.2

671.5

651.4

0.13

369

(44806420)

178

1.52

1.25

2.0

2.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

142

1679

0.84

1.24

2.4

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

115

1.65

1.24

1.9

1.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.40

1.24

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

203

1.48

1.24

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.22

1.24

1.5

1.4

—

(3002256) Pathology report gross observation

868

8136

1.08

1.23

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.86

1.23

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.63

1.21

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

700

1.25

1.20

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

718

1.24

1.20

1.3

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

929

0.79

1.19

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

742

6929

1.08

1.18

3.1

4.5

10.1

25.3

ug/l

4.02

611

5808

(3036071) Salmonella sp Ab [Titer] in Serum

165

1.52

1.17

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

544

1.27

1.14

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

158

1.52

1.14

1.1

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

259

0.62

1.13

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

414

3780

1.10

1.12

2.3

2.4

15.9

24.4

au/ml

0.96

176

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.00

1.12

1.3

1.4

50.6

22.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

111

1.62

1.11

1.2

2.0

77.8

mg/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

119

1.60

1.11

1.4

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

135

1.56

1.11

1.2

1059.9

254.5

pmol/l

0.47

101

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

345

1.34

1.10

1.3

1.4

2.1

1.8

u/ml

0.08

163

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.82

1.08

3.7

6.1

74.9

48.8

ug/min

0.63

(3043410) Blood group antigens tested for on Red Blood Cells

152

1.51

1.08

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

115

966

1.19

1.07

1.1

122.8

1055.1

iu/ml

0.78

202

(3013727) Leukocytes other/100 leukocytes in Blood

202

1.44

1.07

3.1

3.2

58.9

54.8

0.48

192

(3019225) pH of Specimen

671

6274

1.08

1.05

6.1

3.9

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.27

1.03

1.2

1.5

37.6

9.7

nmol/l

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.27

1.03

1.2

1.0

22.1

21.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.27

1.03

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.27

1.03

1.2

1.0

9.2

8.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.27

1.03

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.27

1.03

1.2

1.0

36.0

38.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.96

1.03

1.6

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

252

0.63

1.03

1.2

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

214

0.61

1.00

2.4

2.9

27.0

29.0

umol/l

—

163

(42529582) MDA5 Ab [Presence] in Serum by Line blot

139

1.51

0.99

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

139

1.51

0.99

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

139

1.51

0.99

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

139

1.51

0.99

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

131

1.53

0.99

1.2

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

701

1.21

0.98

1.3

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

283

1.34

0.98

1.2

1.1

7.9

10.8

iu/ml

0.49

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.97

1.3

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

269

2424

1.11

0.97

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.85

0.96

1.6

1.8

52.1

43.1

umol/l

—

(44806071)

1.74

0.96

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.89

0.94

2.4

2.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

216

1929

1.12

0.92

2.8

4.0

83.1

67.6

u/ml

0.43

208

1862

(4133840)

145

0.55

0.92

1.1

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

191

2150

0.89

0.92

1.6

1.7

39.3

42.0

nmol/l

0.95

186

2071

(3040893) Potassium [Moles/volume] in Capillary blood

2.14

0.91

5.2

2.0

4.4

4.3

mmol/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

184

1.41

0.91

1.1

1.6

2.4

5.3

ug/l

1.09

139

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

563

1.23

0.90

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

429

1.26

0.89

2.0

1.8

8.4

6.7

mmol/l

1.66

287

(3025130) Human papilloma virus identified in Specimen

385

1.27

0.89

1.7

1.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.86

0.87

1.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

413

1.26

0.87

1.2

10.1

11.8

mmol/l

1.80

145

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

0.87

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

168

0.59

0.86

1.5

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.78

0.84

1.1

1.0

6.5

6.6

u/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.88

0.81

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

699

1.19

0.81

1.5

1.3

—

(3025577) Chromium [Mass/volume] in Blood

466

0.77

0.81

2.1

1.9

1.8

2.1

ug/l

0.43

376

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

468

5006

0.93

0.81

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

302

1.29

0.80

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

375

0.75

0.80

1.6

1.4

—

(3007461) Platelets [#/volume] in Blood

6790

67439

1.05

0.78

41.1

18.9

230.3

245.0

e9/l

60.42

6646

65199

(3045683) HLA typing for celiac disease panel - Blood or Tissue

270

0.70

0.78

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

277

1.30

0.78

1.1

1.0

1.1

u/l

0.58

147

(3023410) Appearance of Cerebral spinal fluid

574

1.20

0.78

1.6

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.51

0.77

5.6

5.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

246

0.69

0.77

1.0

1.1

669.7

328.8

ng/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.50

0.77

2.8

2.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1039

0.85

0.76

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

0.62

0.75

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

680

0.82

0.75

1.1

1.2

8.1

7.7

mmol/l

0.43

486

(40768804) Tissue Pathology biopsy report

2478

24197

1.04

0.74

2.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

175

1.37

0.74

1.4

1.2

—

(3035941) MCH [Entitic mass]

6791

67471

1.05

0.73

40.9

18.8

30.5

0.90

6697

66230

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.00

0.72

1.0

1.2

282.4

291.3

nmol/l

—

(3024731) MCV [Entitic volume]

6791

67475

1.05

0.72

40.9

18.8

92.2

91.2

55.56

6699

66231

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.80

0.72

13.3

8.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

117

1026

1.14

0.72

2.5

2.3

—

(3026361) Erythrocytes [#/volume] in Blood

6791

67480

1.05

0.71

41.0

18.9

4.4

4.5

e12/l

53.35

6635

64978

(3036670) Protein [Mass/volume] in Synovial fluid

194

1.34

0.71

1.1

1.3

36.4

38.5

g/l

0.26

(3010813) Leukocytes [#/volume] in Blood

6792

67492

1.05

0.70

41.1

18.9

7.2

6.7

e9/l

24.71

6633

64997

(3016031) Almond IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

1.1

0.6

1.9

u/ml

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

160

1.38

0.70

1.4

1.2

0.3

g/l

0.09

127

(3000963) Hemoglobin [Mass/volume] in Blood

6792

67496

1.05

0.70

41.4

19.0

133.5

137.2

g/l

65.11

6701

66238

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

126

1114

1.13

0.69

1.6

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

292

1.27

0.69

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

158

1419

1.12

0.67

1.5

1.4

10.3

8.7

u/l

0.78

125

1146

(3002523) Influenza virus A Ag [Presence] in Specimen

677

1.17

0.67

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.63

0.66

6.3

6.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.63

0.66

1.9

2.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

155

0.64

0.65

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

679

1.17

0.65

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.61

0.65

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

633

1.17

0.65

1.3

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

103

1.46

0.64

1.4

2.7

109.8

143.2

ng/l

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

163

1.35

0.64

1.1

1.2

33.1

39.3

0.32

111

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.72

0.64

1.4

1.6

—

(3015183) Erythrocyte sedimentation rate

235

0.72

0.63

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1372

13299

1.04

0.63

1.7

28899119.4

25779224.8

pmol/l

0.08

1135

10850

(40768793) Breast Pathology biopsy report

923

0.87

0.62

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

153

0.65

0.62

1.4

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.52

0.62

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

261

1.27

0.62

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.67

0.61

1.2

1.3

1.0

0.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

289

1.25

0.60

1.4

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

455

0.81

0.59

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

141

1562

0.90

0.59

1.7

1.9

210.2

203.8

pmol/l

0.30

133

1463

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

281

1.25

0.59

2.1

2.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

114

1.40

0.58

1.0

1.1

1.0

40.5

u/ml

—

(3008898) HLA-B27 [Presence]

135

1497

0.90

0.58

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

501

1.18

0.58

1.9

2.0

1.3

1.8

u/field

0.35

185

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

557

1.17

0.58

1.1

—

2.4

—

(3042517) Benzodiazepines panel - Urine

1.71

0.57

2.2

1.7

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.67

0.56

1.2

1.4

28.8

8.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.67

0.56

1.3

1.4

308.3

347.0

umol/24h

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2256

22095

1.03

0.56

4.5

3.7

—

(40768441) Liver Pathology biopsy report

448

1.18

0.55

1.2

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

107

1.40

0.55

2.3

1.5

197.5

133.2

ng/l

0.46

107

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

556

5825

0.95

0.55

1.5

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

132

1193

1.11

0.54

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

312

1.22

0.54

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

159

0.69

0.54

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.54

0.53

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

772

7430

1.04

0.53

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

313

1.21

0.53

1.3

1.2

—

(4146454)

770

0.87

0.52

2.6

2.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

139

1263

1.10

0.52

2.0

1.7

336.5

293.6

mu/l

0.68

130

1175

(3019150) Specific gravity of Urine by Refractometry

1289

12532

1.03

0.52

4.9

3.9

1.0

kg/l

3.12

172

1957

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.45

0.51

1.1

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.50

0.51

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

152

1389

1.10

0.51

1.8

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

109

1.38

0.50

1.3

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.46

0.50

2.0

2.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

156

0.70

0.49

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.49

0.49

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

335

1.19

0.48

1.2

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

335

1.19

0.48

1.3

1.6

1.2

nmol/l

0.90

250

(3020650) Glucose [Presence] in Urine

155

0.71

0.48

1.1

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

210

1.24

0.44

1.0

1.1

1455.6

1549.4

miu/ml

0.16

210

(3016879) Cocaine [Presence] in Urine

135

1239

1.09

0.44

2.7

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

145

1337

1.09

0.43

1.4

28.7

28.2

iu/l

0.06

111

1116

(3000285) Sodium [Moles/volume] in Blood

1.41

0.43

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.61

0.43

1.0

1.1

283.2

692.1

u/l

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

284

0.81

0.42

9.9

12.2

0.5

0.6

mmol/l

1.71

260

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.56

0.42

1.8

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.56

0.42

4.0

4.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.41

3.5

2.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.43

0.41

1.0

—

(1002224) Polysomnography panel

207

2208

0.94

0.41

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

3.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.47

0.40

1.0

1.1

—

4.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

364

3473

1.05

0.40

3.2

2.7

0.4

0.3

e6/l

0.91

358

3406

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

241

1.20

0.40

2.0

1.8

26.5

29.3

umol/l

1.20

231

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.39

0.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

717

0.89

0.38

1.1

1.5

1.4

u/ml

0.08

323

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

247

0.81

0.38

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

147

0.75

0.37

2.0

2.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

841

0.90

0.37

1.2

1.1

0.5

1.3

u/ml

2.46

359

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

107

1.31

0.37

1.1

1.7

2.4

2.5

ug/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

1.24

0.37

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

849

1.10

0.36

6.6

3.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

129

1390

0.93

0.36

5.2

3.1

26.3

29.3

mg/l

0.48

869

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

608

0.89

0.36

1.0

1.1

—

17.6

—

(4211845)

310

0.84

0.36

2.2

3.1

—

(37021550) Renin [Units/volume] in Plasma --upright

135

1.26

0.35

1.5

1.3

173.5

59.9

mu/l

0.71

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

247

1.17

0.32

2.8

2.2

68.8

53.8

umol/l

1.04

197

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

247

1.17

0.32

1.4

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

455

0.88

0.32

1.4

24.1

27.5

u/l

0.33

368

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

0.79

0.32

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

220

1.18

0.31

1.0

1.1

7.5

7.0

u/ml

—

(44813793)

333

1.14

0.31

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.73

0.30

1.0

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

142

0.77

0.30

1.3

1.2

—

582.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

118

1263

0.93

0.30

1.2

1.1

9.6

6.8

u/ml

0.29

145

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

102

1.27

0.30

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.29

0.30

2.1

2.6

89.0

65.3

pmol/l

0.37

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

138

1297

1.07

0.29

1.4

1.5

54.6

17.4

e6/l

0.44

104

980

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

345

1.13

0.28

1.1

1.6

10.6

nmol/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

450

0.89

0.28

1.1

1.0

1.9

0.7

u/ml

0.37

121

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

138

1300

1.06

0.27

1.5

816.0

2820.4

e6/l

0.59

110

1039

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

161

0.81

0.27

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

141

1333

1.06

0.26

2.7

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.25

0.25

1.0

—

(3028300) Cannabinoids [Presence] in Urine

141

1336

1.06

0.24

2.7

2.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

507

0.91

0.24

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

138

1309

1.06

0.23

1.3

3.8

mmol/l

0.20

128

1237

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.32

0.23

1.4

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.32

0.23

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

137

1301

1.05

0.23

2.8

2.2

—

(4027681)

304

1.12

0.22

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

139

1322

1.05

0.22

2.7

2.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

295

1.12

0.22

6.1

6.6

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.22

0.22

2.2

1.4

2.7

0.9

—

(3051101) Glucose [Moles/volume] in Cord blood

135

0.81

0.22

7.8

6.5

—

(3006270) Folate [Moles/volume] in Blood

534

0.92

0.21

1.2

1.1

371.9

343.6

nmol/l

0.37

430

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

332

3224

1.03

0.20

3.9

3.4

—

(3024869) Neuronal Ab [Presence] in Serum

117

1.20

0.20

1.0

1.1

—

(3001729) Color of Synovial fluid

1.25

0.20

2.0

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

665

0.93

0.19

1.1

1.4

2.8

u/ml

0.83

159

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

197

0.86

0.19

2.1

2.4

138.1

145.2

nmol/l

0.12

172

(3028717) Thiamine [Mass/volume] in Blood

1.17

0.17

1.4

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

649

1.06

0.17

1.3

1.2

—

(4094501)

166

1600

1.04

0.17

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.76

0.17

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

547

0.93

0.17

1.2

1.1

5.5

3.8

u/ml

0.27

222

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

588

0.93

0.17

1.4

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.72

0.16

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

148

1.15

0.16

2.1

2.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

731

0.94

0.16

1.1

6.7

4.6

u/ml

0.47

384

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.78

0.15

1.3

1.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

182

0.88

0.15

1.4

1.2

17.2

18.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

366

3584

1.02

0.14

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.79

0.14

1.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

374

1.07

0.12

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

509

0.94

0.12

1.1

6.0

4.8

u/ml

0.11

209

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

162

1.11

0.11

3.6

3.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

425

1.06

0.11

1.2

1.5

1.0

g/l

0.34

425

(3006462) Nitrate [Presence] in Urine

281

0.92

0.11

2.2

3.2

—

(3045424) Erythrocytes [Presence] in Urine

100

1035

0.97

0.11

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

398

4041

0.98

0.10

2.9

3.0

4.6

4.1

e9/l

3.59

292

3012

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

879

1.04

0.10

1.7

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

419

1.05

0.09

4.6

5.1

28.0

67.7

u/ml

1.60

135

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

321

1.06

0.09

1.4

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

165

0.91

0.08

1.3

3.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1521

15296

0.99

0.08

3.9

3.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.77

0.08

1.6

2.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.77

0.08

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.09

0.08

1.7

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.03

0.07

1.0

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1617

16249

0.99

0.07

1.6

1.5

1.4

mmol/l

4.57

1366

13532

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.83

0.07

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

215

0.93

0.07

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

137

1.09

0.07

1.1

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.87

0.06

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

306

1.05

0.05

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

263

0.95

0.05

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

633

0.98

0.03

3.4

2.9

36.8

40.4

mg/l

0.07

455

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

171

1.05

0.03

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

451

1.02

0.02

1.4

0.2

nmol/l

1.24

349

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

451

1.02

0.02

1.5

1.6

—

(40762814) Titanium [Mass/volume] in Blood

133

1.05

0.01

2.6

2.1

3.0

3.9

ug/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

412

1.02

0.01

1.1

4.4

2.8

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

227

0.97

0.01

1.0

1.1

0.6

1.5

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

787

0.99

0.01

1.8

1.9

23.4

30.4

mg/l

0.48

196

(4015189)

150

1.00

0.00

1.7

2.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

154

0.97

0.00

2.7

3.8

7.5

7.8

mg/l

—

123

(3022689) Creatine [Moles/volume] in Urine

195

0.97

0.00

1.7

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.05

0.00

1.5

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

132

0.98

0.00

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

141

1408

1.00

0.00

2.3

3.5

773.1

808.5

u/ml

0.03

125

1284

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

140

1.00

0.00

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

189

1.01

0.00

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

882

1.00

0.00

4.6

4.7

344.8

351.7

umol/l

0.17

735

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

633

1.00

0.00

1.1

2.7

3.1

u/ml

0.21

274

(3020874) Milk IgE Ab [Units/volume] in Serum

232

0.99

0.00

1.1

0.8

1.4

u/ml

0.52

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

248

1.01

0.00

1.2

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

258

1.01

0.00

1.7

1.2

71.1

65.8

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.02

0.00

1.2

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.96

0.00

2.6

1.8

115.9

50.8

pmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.92

0.00

1.6

2.0

17.7

18.1

umol/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.91

0.00

1.5

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.96

0.00

1.9

1.6

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

24.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.01

0.00

1.1

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1542.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.97

0.00

1.7

2.7

0.2

0.3

u/field

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.01

0.00

1.3

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDMYO and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CARDMYO	2.494 [2.27, 2.74]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.212

During the follow-up period (1.1.1998 — 31.12.2019), 4442 out of 13050 females with I9_CARDMYO died.

Males

Parameter	HR [95% CI]	p-value
I9_CARDMYO	2.801 [2.55, 3.08]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 10866 out of 26799 males with I9_CARDMYO died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDMYO.

N-year risk	Females	Males
1	0.299%	0.505%
5	1.513%	2.841%
10	3.438%	7.203%
15	6.214%	13.511%
20	11.01%	22.488%

Relationships between endpoints

↥

Index endpoint: I9_CARDMYO – Cardiomyopathy

GWS hits: 24

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiomyopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints